The Doctrine of Equivalents is a U.S. patent law rule that can make an accused product, accused device, or accused process infringe a patent even when it does not literally infringe the exact claim language of the asserted patent. The doctrine limits the available design-around options for products and services that are similar to the claimed invention. It is not enough to simply avoid the literal wording of a specific patent claim. A similar product, technology, or service may still infringe the patent if the substitute technology performs the same function in substantially the same way to achieve substantially the same result. This article provides an explanation of what the doctrine of equivalents is and how it affects patent infringement.
This article is intended for business owners, patent professionals, and anyone interested in understanding how the doctrine of equivalents affects patent infringement.
Patent infringement is defined by statute. 35 U.S.C. § 271(a) prohibits making, using, selling, offering to sell, or importing a patented invention within the United States, or importing it into the United States, without authority from the patent owner. In practice, the patent infringement analysis usually starts with the patent claim, often an independent claim, because the claims, not the abstract, drawings, or general description, define the legal boundaries of the patent rights. A court first performs claim construction to determine the meaning of the claim language from the perspective of a person of ordinary skill in the art. This is a formal process referred to as a Markman hearing under Markman v. Westview Instruments, 517 U.S. 370 (1996)(which is explained in more detail in our Markman hearing article). The court studies the claim language, the patent’s specification, the prosecution history, and sometimes extrinsic evidence to determine the claim construction. The literal meaning of the claim matters because the doctrine of equivalents extends only beyond, not instead of, the literal claim. The court then compares the properly construed claim to the accused product or process.
For literal infringement, every claim limitation must be found in the accused product or process. If even one claimed element is missing, there is no literal infringement of that particular claim. Conversely, if every claimed element is present within the literal scope of the patent claim, the accused product or process infringes literally. This claim-by-claim and element-by-element framework is also important when considering the doctrine of equivalents, because equivalents cannot be used to ignore or eliminate a specific claim limitation.
The doctrine of equivalents addresses the situation where an accused infringer changes one feature of a product or process but keeps the practical substance of the invention. In other words, a business cannot always avoid patent infringement simply by replacing a component with a slightly different version if the replacement does the same work in the same practical manner. Equivalent infringement can establish infringement even without elements identical to the claims recited in the patent.
The key issue is whether an accused element or substitute element is equivalent to the claimed element in the relevant patent claim. Courts do not ask whether the accused product generally resembles the patented invention as a whole. Instead, the analysis focuses on each claim limitation individually. If a claimed element is missing literally, the patent owner may argue that the substitute element performs the same function, in substantially the same way, to achieve the same result.
This doctrine is important because patent claims are written in words, but technology often evolves through minor changes in form, materials, software logic, or mechanical arrangement. Without the doctrine of equivalents, an accused infringer could sometimes avoid liability through an insubstantial design change that captures the benefit of the claimed invention while avoiding the literal wording of the claim. At the same time, the doctrine is limited. It cannot expand a patent to cover the prior art, erase meaningful claim language, or recapture subject matter surrendered during patent prosecution through prosecution history estoppel.
In Graver Tank & Manufacturing Co. v. Linde Air Products Co., 339 U.S. 605 (1950), the Supreme Court gave the doctrine of equivalents its classic modern formulation. The case involved welding-flux claims in the Jones patent. The claimed composition used a combination of alkaline earth metal silicate and calcium fluoride. The accused Lincolnweld flux used calcium and manganese silicates instead of calcium and magnesium silicates, meaning the accused composition did not literally track the patent claim language. The district court nonetheless found infringement, and the Supreme Court affirmed because the substitution was insubstantial in light of the technology and prior art. The Court explained that equivalence depends on context: the patent, the prior art, the purpose of the ingredient, its qualities in combination, its function, and whether persons reasonably skilled in the art would have known the materials were interchangeable.
The resulting “function-way-result” or triple identity test asks whether a substitute element performs substantially the same function, in substantially the same way, to achieve the same result as the claimed element. In practical terms, the Graver Tank test assesses function, way, and result. If a substitute element matches those points, and the differences are not substantial when viewed through the eyes of a person skilled in the art, a court may find equivalence even without literal infringement. The takeaway is that changing a material, component, or step may not avoid patent infringement if the change is merely colorable and preserves the practical operation of the claimed invention.
In Warner-Jenkinson Co. v. Hilton Davis Chemical Co., 520 U.S. 17 (1997), the Supreme Court reaffirmed the doctrine of equivalents while limiting how it may be used to prove patent infringement. The Hilton Davis patent concerned an ultrafiltration process for purifying dyes. The relevant claim required the process to operate at a pH between 6.0 and 9.0. The accused process used a pH of 5.0, so Hilton Davis conceded there was no literal infringement and relied on equivalence. The Court preserved the doctrine, but rejected any free-ranging comparison between the overall accused process and the patented invention. Instead, the Warner-Jenkinson test emphasizes the insubstantial differences test and requires an objective, element-by-element inquiry focused on each claimed element. The Court also made clear in 1997 that the “all elements” test applies to each claim element individually, meaning the doctrine cannot erase or ignore a limitation from the relevant claim. The decision also tied equivalence to prosecution history estoppel: when the reason for a narrowing amendment is unclear, the patentee bears the burden to show the amendment was not made for patentability reasons.
A patentee cannot establish infringement under the Doctrine of Equivalents by arguing that “our invention is close enough overall.” In Warner-Jenkinson, the Supreme Court emphasized that the equivalents analysis must be applied to each claim limitation individually. Each claimed element must be either literally present in the accused product or accused process, or equivalently present through an accused feature that differs only insubstantially. This “all elements” rule prevents the doctrine from expanding a patent claim so broadly that a limitation disappears from the claim language. Courts therefore compare the accused feature with the claimed feature and ask whether it performs substantially the same function, in substantially the same way, to achieve the same result, or whether the differences are meaningful.
The doctrine cannot let a patentee capture what already existed in the prior art or what the patentee disclosed but chose not to claim. In Wilson Sporting Goods Co. v. David Geoffrey & Assocs., 904 F.2d 677 (Fed. Cir. 1990), Wilson asserted doctrine of equivalents infringement against Dunlop golf balls that used a similar icosahedral dimple pattern but did not meet the literal claim limitation requiring that no dimples intersect the ball’s “great circles.” The Federal Circuit held that a court may test the asserted range of equivalents by drafting a hypothetical claim broad enough to cover the accused product and asking whether that claim would have been patentable over the prior art. Because Wilson’s hypothetical claim would have ensnared the prior-art Uniroyal ball, the claim could not reach Dunlop’s balls under equivalents.
In Johnson & Johnston Assocs. Inc. v. R.E. Serv. Co., Inc., 285 F.3d 1046 (Fed. Cir. 2002), the patent claimed copper foil laminated to aluminum, while the patent’s specification disclosed stainless steel as an alternative substrate. The accused products used steel. The Federal Circuit held that, under the disclosure dedication rule, disclosed but unclaimed subject matter is dedicated to the public and cannot be recaptured through the doctrine of equivalents.
Prosecution history estoppel limits doctrine of equivalents application by preventing a patentee from using equivalents to recapture claim scope surrendered during patent prosecution. In Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 535 U.S. 722 (2002), Festo owned patents for a magnetically coupled rodless cylinder; after amendment, the asserted claims required sealing rings and a magnetizable sleeve. The defendant sold a similar accused device using a single two-way sealing ring and a nonmagnetizable sleeve, and Festo alleged infringement under the doctrine of equivalents. The Supreme Court held that narrowing claim amendments made to secure allowance can trigger estoppel, whether made to overcome prior art or to satisfy other Patent Act requirements, including formal matters such as the written description, enablement, and definiteness requirements under 35 U.S.C. § 112.
The Court also rejected the Federal Circuit’s complete-bar rule, holding instead that estoppel creates a presumption of surrender that may be rebutted when the equivalent was unforeseeable, the amendment’s rationale bore only a tangential relation to the equivalent, or another reason shows the patentee could not reasonably have described it. Patent prosecutors should draft claims, amendment remarks, and arguments carefully because avoiding prosecution history estoppel often depends on preserving a clear record that no relevant subject matter was surrendered. USPTO replies and amendments can be properly filed under 37 C.F.R. § 1.111 without excess arguments or claim limitations. A response to an office action should address each issue in an office action succinctly and create as little prosecution history as possible.
Estoppel can arise not only from amendments but also from arguments. Argument-based estoppel occurs when the patentee makes a clear and unmistakable surrender of claim scope to the USPTO. In Amgen Inc. v. Coherus BioSciences Inc., 931 F.3d 1154 (Fed. Cir. 2019), Amgen asserted the doctrine of equivalents against Coherus for a protein-purification process using a salt combination not literally recited in the patent claims. During prosecution, however, Amgen had distinguished prior art by emphasizing the “particular” salt combinations in the claims. The Federal Circuit affirmed dismissal, holding that Amgen’s prosecution arguments surrendered unclaimed salt combinations and barred equivalence.
Statements made in foreign patent offices can also affect the analysis. In Tanabe Seiyaku Co. v. U.S. International Trade Commission, 109 F.3d 726 (Fed. Cir. 1997), the patent covered a process for making diltiazem using specific base-solvent combinations, while the accused process substituted butanone for acetone. The court held that foreign prosecution statements to the EPO, Finland, and Israel did not create a separate “foreign prosecution estoppel,” but were relevant to whether a skilled person would view the substitute element as interchangeable.
Prosecution history estoppel may also affect related patents. In Elkay Manufacturing Co. v. Ebco Manufacturing Co., 192 F.3d 973 (Fed. Cir. 1999), the court held that prosecution history for a claim limitation in one patent can apply to later related patents containing the same relevant subject matter.
When asserting infringement under the doctrine of equivalents, a patent owner must do more than show general similarity between the accused product and the patented invention. U.S. courts generally require particularized testimony and a linking argument tying each accused feature or substitute element to a specific claim limitation. See AquaTex Industries, Inc. v. Techniche Solutions, 479 F.3d 1320 (Fed. Cir. 2007). This proof must address the legal test element by element, often using technical expert evidence to explain why any differences are insubstantial. A jury verdict on equivalence must be supported by substantial evidence, and a district court may test the sufficiency of that proof.
The U.S. is unique in how it approaches determining infringement by equivalents. German courts use a three-step test, asking whether the variant has the same effect, whether that would have been discoverable to the skilled person, and whether the reasoning remains oriented to the claim’s technical teaching. UK courts apply their own framework, including whether a variant achieves substantially the same result in substantially the same way, whether that would be obvious to a person having ordinary skill in the art (PHOSITA) at the priority date, and whether a PHOSITA would think the patentee nonetheless intended strict compliance with the literal meaning of the claim. These approaches are not entirely different, but there are important variances.
The Doctrine of Equivalents is a flexible but limited legal rule. It protects the inventive concept captured in a patent against insubstantial copying, but it does not rewrite the claim, erase the all elements test, recapture surrendered territory, or cover the prior art. Business owners need to understand this aspect of patent law because it expands the scope of a patent claim beyond the literal words in the patent claim. The infringement analysis is not limited to whether an accused product falls within the literal scope of one claim, but also whether each substitute element performs substantially the same function, in substantially the same way, to reach the same result.
© 2026 Sierra IP Law, PC. The information provided herein does not constitute legal advice, but merely conveys general information that may be beneficial to the public, and should not be viewed as a substitute for legal consultation in a particular case.
Trademark classes are the numbered categories used in trademark registration to describe the goods and services sold under a mark. They are a critical feature of the trademark application process because the applicant's goods and services must be placed in the proper classes at the time the trademark application is filed. The trademark class(es) also affect filing costs, trademark search strategy, the risk of refusal by the trademark examiner, and the practical scope of protection.
A trademark application must identify the goods or services for which the mark is used or will be used. Goods are tangible products customers buy and use, such as clothing, software sold as downloadable products, food items, or machinery. Services are intangible activities performed for the benefit of others, such as online retail store services, business consulting, entertainment, education, medical care, or legal services. The USPTO uses trademark classes to organize goods and services, assess fees, and aid searching its database of registered and pending marks. They help applicants describe their commercial activity, help the USPTO assess fees, and aid searching its database of registered and pending marks.
Choosing the correct class matters because a registration generally protects the mark only for the identified goods or services, not for every possible product or business activity. A company may need one class or multiple classes if the same brand is used across different offerings. Class selection also affects clearance searching, because similar marks in related or coordinated classes may still create a likelihood of confusion even if they are not in the same class. In short, trademark classes define the commercial context in which trademark rights are examined, registered, and enforced.
The Nice Classification system, established by the Nice Agreement in 1957 and administered through the World Intellectual Property Organization (WIPO), is the global framework for grouping trademark-related goods and services into standardized international trademark classes. Instead of requiring every country to create its own incompatible class labels, the system uses a shared classification system that allows applicants, trademark offices, and searchers to describe products and services in a consistent way. For business owners, that consistency matters because it makes international trademark filing, Madrid-based international registration, and cross-border clearance more predictable. A company seeking protection for computer software, medical devices, clothing, or business services can often begin with the same international classes when evaluating filings in different jurisdictions. The class number does not decide by itself whether trademark infringement occurred, but it helps organize searches, compare competitors’ filings, identify related goods or services, and reduce avoidable errors when expanding a brand internationally.
How many trademark classes are there? There are 45 international classes in the Nice Classification system. Classes 1–34 cover goods, meaning tangible products such as clothing, software, food, machinery, chemicals, and building materials. Classes 35–45 cover services, meaning activities performed for others, such as advertising, business management, education, legal services, medical services, and retail store services. The system began with 34 goods classes and later expanded to include 11 services class categories. Each trademark application must identify at least one class, and protection generally tracks the selected goods or services listed in the application.
Choosing the appropriate class matters because a trademark application must explain exactly how the mark is or will be used. The United States Patent and Trademark Office (USPTO) requires at least one class, and 37 C.F.R. § 2.32 requires the application to include a list of the particular goods or services and the fee for each class. A registration generally protects the trademark only in the class or classes identified in the application and only for the listed goods and services, not for every possible business activity. For example, a mark registered for clothing does not automatically protect unrelated software, food products, or legal services. The class also affects USPTO filing fees because each class requires a separate fee. Selecting the wrong class can lead to an Office Action, delays, added costs, or a narrower registration than expected. Careful classification helps define the trademark’s commercial scope and supports stronger trademark registration strategy.
The first 34 trademark classes cover goods, meaning physical products that customers buy, use, consume, wear, install, or otherwise receive as tangible items. These classes are organized partly by product function and partly by material composition. For example, some classes focus on chemicals, cosmetics, foods, machines, electronics, clothing, or building products, while others group products based on whether they are made of metal, paper, textile, synthetic materials, or other materials.
The class should match the actual product sold under the mark. A company selling fertilizer, for example, will likely look at a different class than a company selling cosmetics, metal hardware, or automatic vending machines. The following examples illustrate how the goods classes begin to operate in practice:
While goods classes cover tangible products, services classes cover intangible activities performed for the benefit of others. In the trademark context, a service is performed for customers, clients, members, or the public, such as advertising, consulting, banking, construction, education, healthcare, or legal services. However, advertising for your own business is not providing services you are providing in commerce under trademark law, and does not support any trademark rights or registration. Services have to be provided to another.
Selecting the correct services class is important because the trademark application must accurately describe how the mark is used in commerce. A company that offers consulting, education, professional, healthcare, or other services should identify the class that best matches the actual customer-facing service. Common services classes include:
Searching the USPTO trademark ID manual for similar products can help identify class choices and reveal how examiners may view related goods or services. It is also important to search the USPTO trademark search system and use the coordinated classes options in your trademark search because certain products may fall into classes that are closely related even when they are not in the same class. For example, clothing in Class 25 may be related to jewelry in Class 14 or retail services in Class 35 if consumers would expect them to come from the same brand. Searching for similar marks in these coordinated classes helps applicants identify potential conflicting trademark filings and avoid potential likelihood of confusion issues.
A single trademark application may cover multiple classes when a brand is used for different goods or services, but the USPTO charges filing fees separately for each class. Under the USPTO’s current electronic filing framework in the Trademark Center, which recently replaced many functions of the Trademark Electronic Application System (TEAS), the base application fee is $350 per class for Section 1 and Section 44 applications that meet base requirements. That means a two-class application generally starts at $700, and a three-class application starts at $1,050. Additional USPTO fees may apply for incomplete information, custom identifications, or later use-related filings, so class selection directly affects total cost.
Using the Trademark ID Manual facilitates finding pre-approved descriptions of goods and services, which can lower filing fees, and expedite approval. Filing also requires use in commerce or a bona fide intent to use the mark in the near future. 15 U.S.C. § 1051(b) expressly permits an intent-to-use application based on a bona fide intention to use the mark in commerce. Selecting the wrong class or using vague wording can trigger an Office Action, which may require amendment, added-class fees, or refiling if the problem cannot be corrected within the application.
A registration in one class does not automatically prevent another party from registering the same trademark in a different class, or even in the same class, if the respective goods or services are sufficiently unrelated and consumers are unlikely to believe they come from the same source. For example, Delta Airlines and Delta faucets coexist because of the unrelatedness of their respective services and goods. The controlling question under 15 U.S.C. § 1052(d) is whether the applicant’s mark, as used with the identified goods or services, is likely to cause confusion, mistake, or deception. For example
The leading case, In re E.I. du Pont de Nemours & Co., 476 F.2d 1357 (C.C.P.A. 1973), identifies the multi-factor likelihood-of-confusion test used by the USPTO and courts. The du Pont factors show why two identical marks can sometimes coexist: the analysis considers not only the similarity of the marks, but also the relatedness of the goods or services, trade channels, purchasers, market conditions, and evidence of actual confusion.
In In re 1729 Investments LLC, Serial No. 90694523 (TTAB Apr. 24, 2023), the TTAB reversed a likelihood-of-confusion refusal and allowed the applicant to pursue registration of RAO’S for wine in Class 33 despite existing RAO’S registrations for restaurant and bar services in Classes 42/43. The Board found the marks identical, but held that the USPTO had not shown the required relatedness between the identified wine and restaurant/bar services, particularly in view of the applicant’s trade-channel restrictions and the sophistication of purchasers.
Accordingly, the same mark may be simultaneously registered when the records show commercially distinct goods or services, different trade channels, and no likely consumer confusion.
Trademark classes are more than filing categories. Trademark classes help business owners and entrepreneurs describe what they sell, compare competitors, budget filing fees, and avoid preventable refusals. Best practices include searching the USPTO database, reviewing coordinated classes, and checking the Trademark ID Manual for proper classification of goods and services and choosing the appropriate class or multiple classes that match actual use or bona fide intent. Careful class selection can reduce filing mistakes, avoid unnecessary USPTO fees, lower the risk of an Office Action, and help ensure that the resulting registration reflects the real scope of the business’s brand use.
If you need assistance with a trademark application or other trademark matter, please contact our office to work with our skilled trademark attorneys.
© 2026 Sierra IP Law, PC. The information provided herein does not constitute legal advice, but merely conveys general information that may be beneficial to the public, and should not be viewed as a substitute for legal consultation in a particular case.
A Copyright Licensing Agreement is a legally binding contract in which a copyright owner gives another party permission, through a copyright license, to use a creative work or other copyrighted material for a specific purpose under specific conditions. A license agreement is important because it turns informal approval into defined rights granted, obligations, and limits. The document should identify the parties, describe the work, state who retains ownership, and explain whether the license is exclusive, non-exclusive, limited by territory, or limited to a particular time period. It should also address restrictions on copying, distribution, sublicensing, modification, derivative works, and unauthorized use. Payment terms may include a one-time fee, royalties, or other compensation tied to the licensee’s use. A termination clause should explain when the license ends and what happens afterward. Clear terms reduce disputes and help protect intellectual property while allowing lawful commercial use.
A strong copyright licensing agreement starts with accurate basic information. The licensing agreement should list the full legal names, addresses, entity types, company details, and signing authority for all parties involved, including the licensor, the licensee, and any parent, affiliate, agent, or authorized representative signing on behalf of a company. This matters because the license granted is only reliable if the party granting it actually has the authority to do so. The effective date should also be stated clearly, along with any start date for access, delivery, or permitted use.
The agreement should identify the copyrighted work with enough specific details to avoid confusion. For example, the contract may cover photographs, website copy, videos, music, training content, software, product illustrations, marketing materials, or other creative work. Attachments, file names, copyright registration numbers, version numbers, URLs, titles, creation dates, and approved formats can help define the exact copyrighted material being licensed.
The agreement should also confirm accurate ownership of the copyright and any associated intellectual property rights. Under U.S. copyright law, copyright initially belongs to the author unless the work is a work made for hire or ownership has been transferred. See 17 U.S.C. §§ 101, 201. If the agreement includes an exclusive license or other transfer of copyright ownership, it must be in writing and signed by the copyright owner or authorized agent, as required by 17 U.S.C. § 204(a). The contract should also specify whether related rights are included, such as trademarks, trade secrets, publicity rights, source code access, or third-party materials. Clear ownership language helps prevent later disputes over the rights granted, restrictions, and lawful use.
Licensing agreements can be exclusive, non-exclusive, sole, or based on standardized Creative Commons licenses. In U.S. copyright law, the starting point is the copyright owner’s bundle of exclusive rights, including reproduction, distribution, public performance, public display, and preparation of derivative works under 17 U.S.C. § 106.
An exclusive license gives one licensee the sole right to use designated copyrighted material within the stated scope, territory, and time period. In practice, the licensor may not grant the same specific rights to another party, and the copyright owner may be barred from exercising those rights if the agreement makes the license exclusive and there is no reservation allowing the owner to exercise such rights. Under U.S. copyright law, an exclusive license is a “transfer of copyright ownership,” even when limited by duration or territory, and unlike a nonexclusive license, it must be in a written agreement signed by the owner or authorized agent to be valid. 17 U.S.C. §§ 101, 204(a). The clause should identify the exclusive rights being granted, such as reproduction, distribution, display, performance, or creation of derivative works under 17 U.S.C. § 106, and reserve all other rights to the licensor. Because an exclusive licensee may have standing to sue for infringement of the licensed rights under 17 U.S.C. § 501(b), the parties should address enforcement obligations, costs, and notice requirements so that the parties coordinate in copyright enforcement.
An exclusive license should not be confused with a full copyright assignment. An assignment transfers ownership of the copyright, or a specified ownership interest, from the copyright owner to another party. After an assignment, the assignee owns the assigned rights and may generally control, enforce, sell, or further license those rights, subject to any contractual limits. An exclusive license, by contrast, grants the licensee exclusive permission to exercise particular rights while the licensor may retain overall ownership and all rights not expressly granted. In short, an assignment changes who owns the copyright interest, while an exclusive license controls who may use defined rights.
A nonexclusive license lets the copyright owner grant the same license to use a copyrighted work to multiple licensees at the same time. Unlike an exclusive license, it does not transfer copyright ownership. 17 U.S.C. § 101 defines a transfer of copyright ownership to include an assignment or exclusive license, but not a nonexclusive license. Because 17 U.S.C. § 204(a)’s writing requirement applies to transfers of copyright ownership, nonexclusive licenses may be written, oral, or implied from conduct. In Effects Associates, Inc. v. Cohen, 908 F.2d 555 (9th Cir. 1990), a filmmaker hired Effects Associates to create special-effects footage for the movie The Stuff, paid less than the agreed amount, and used the delivered footage in the film without a signed copyright license. The Ninth Circuit held that Effects had impliedly granted a nonexclusive license because it created the footage at Cohen’s request, delivered it for use in the film, and intended Cohen to copy and distribute it as part of the movie. Thus, while a nonexclusive license can arise informally, it is preferable to have a written agreement that defines the scope, territory, time period, payment terms, restrictions, and whether the licensee may reproduce, display, distribute, perform, or create derivative works from the copyrighted material.
A sole license is a contract-based middle ground between an exclusive license and a nonexclusive license. In a sole license, the licensor agrees not to grant the same license to use the copyrighted material to any other licensee, but the copyright owner keeps the right to use the work itself. This contractual structure can be useful when a business wants market protection without paying for a fully exclusive grant. The agreement should carefully identify the rights granted, such as reproduction, distribution, display, performance, or creation of derivative works, because U.S. copyright law treats those rights as separate exclusive rights under 17 U.S.C. § 106.
Creative Commons licenses are standardized public copyright licenses that allow a copyright holder to give advance permission for certain uses of a creative work. Common versions include CC BY, CC BY-SA, CC BY-ND, CC BY-NC, CC BY-NC-SA, and CC BY-NC-ND. These licenses can be helpful for online content, educational materials, photographs, and other creative assets, but they are not one-size-fits-all. For example, some allow commercial use, some prohibit it, some allow adaptations, and some restrict derivative works. A business owner should confirm the specific conditions before relying on a Creative Commons license, especially using third party creative materials for advertising, software, trademarks, or paid products.
The grant of rights is the heart of a copyright licensing agreement because it identifies the exact copyright license being given. Under U.S. copyright law, the copyright owner controls a bundle of exclusive rights, including the rights to reproduce the copyrighted work, prepare derivative works, distribute copies, publicly perform the work, publicly display the work, and, for sound recordings, perform the work through certain digital audio transmissions. See 17 U.S.C. § 106.
The grant clause should not rely on broad phrases like “use the work.” Instead, the agreement should state exactly what the license allows the licensee to do: view, download, copy, reproduce, modify, edit, display, publish, provide access to, sublicense, sell, or distribute the copyrighted material. It should also state whether the rights granted include the right to create derivative works, such as translations, adaptations, updated versions, excerpts, compilations, or customized marketing materials.
The clause should also define the scope of the license, including territory, platform, media, time period, specific purpose, and any restrictions or approval rights. Finally, the licensor should reserve all other rights not expressly granted so the licensee does not assume broader permission than the contract actually provides.
A solid copyright license agreement should define the scope of the license with practical precision. The agreement should identify the approved media, platforms, number of copies, audience, sales or marketing channels, territory, and specific purpose for which the licensee may use the copyrighted work. For example, a licensing agreement might allow use of an image on a company website in the United States for one year, but not in paid advertising, merchandise, social media campaigns, or international distribution.
In U.S. copyright law, the copyright owner controls distinct exclusive rights, including reproduction, preparation of derivative works, distribution, public performance, and public display. Because those rights can be licensed separately, the agreement should clearly identify the specific rights granted to the licensee, while expressly reserving all other rights to the copyright owner.
Use restrictions should also state when prior written consent is required. Common restrictions include sublicensing, editing, translating, adapting the work, using it in advertising, combining it with third party material, creating derivative works, transferring the license, or expanding the use into new platforms or territories. This level of detail helps prevent unauthorized use and disputes over whether a particular use falls inside or outside the license.
The payment terms should state exactly how and when the licensee will compensate the licensor for the license. Copyright license agreements commonly use two payment types: a copyright fee, often a one-time payment due on signing, delivery, or the effective date, and royalty fees, which are ongoing payments tied to revenue, usage, downloads, subscribers, views, sales, or another measurable metric. Because a copyright owner controls exclusive rights such as reproduction, distribution, public display, public performance, and derivative works, the payment clause should match the actual rights granted and the permitted scope of use.
The clause should also cover invoices, due date, taxes, reports, audit rights, late payment interest, currency, and whether the license remains valid only if amounts are paid. This distinction matters because a missed payment may create only a contract claim unless the agreement makes payment a condition of the license. In Graham v. James, 144 F.3d 229 (2d Cir. 1998), Richard Graham hired Larry James to convert a CD-ROM retrieval program from BASIC into C++. James owned the copyright in the C++ version, but the parties had a licensing agreement under which Graham could use the program in CD-ROM releases in exchange for payment of $1,000 per release plus $1 per disk sold. Graham later failed to pay royalties and removed James’s copyright notice. The Second Circuit held that those breaches did not automatically convert Graham’s licensed use into copyright infringement because the payment and notice provisions were covenants, not express conditions limiting the scope of the license. The court therefore distinguished between breach of contract and infringement. Use outside the licensed rights, however, may still trigger infringement under 17 U.S.C. § 501.
Most licensors retain original copyright ownership in a copyright licensing agreement. The agreement grants permission to use the copyrighted work, but it does not transfer title unless the contract expressly states that ownership or specific intellectual property rights are being assigned. Copyright ownership may be transferred in whole or in part, but an exclusive license or assignment should be clearly documented in writing. See 17 U.S.C. §§ 101, 201(d), 204(a).
The agreement should also address attribution, including whether the licensee must credit the copyright owner, author, company, or creator, and the exact form of that credit. Attribution terms are especially important for creative work used in advertising, software, publications, social media, or branded content. For certain works of visual art, 17 U.S.C. § 106A provides limited rights of attribution and integrity, separate from ordinary ownership rights.
A non-disclosure clause may be essential when the licensee receives source files, unpublished materials, customer data, pricing, know-how, technical documentation, business plans, or trade secrets. This clause should define the protected information, limit disclosure to employees or contractors with a need to know, require reasonable safeguards, and state whether confidentiality obligations survive termination of the agreement. Under U.S. law, trade secret protection depends in part on taking reasonable measures to keep the information secret under 18 U.S.C. § 1839(3).
The agreement should also address practical business obligations, including implementation assistance, technical support, audit rights, quality control, and whether the licensee must obtain prior written consent before using third-party fonts, stock images, music, plug-ins, trademarks, or other rights.
A non-compete clause may be included that provides competitive restrictions in a broader commercial arrangement involving intellectual property, software, proprietary workflows, or sensitive market information.
A strong termination clause should identify the events that end the copyright license, including breach of contract, failure to pay, unauthorized use, insolvency, reputational misuse, failure to obtain required approvals, or use outside the granted rights. The clause should require written notice, state whether the breaching party has a cure period, and explain what happens after termination. For example, the licensee may need to stop using the copyrighted material, remove it from websites or products, delete digital files, return confidential materials, cease distribution activities, and provide written certification of compliance.
This matters because once the agreement expires or is terminated, continued use may exceed the rights granted and become copyright infringement under U.S. copyright law. Conduct that was permitted during the license term may become actionable unauthorized use after termination.
Indemnification clauses allocate legal risk if a third-party claims that use of the copyrighted work infringes its intellectual property rights, violates privacy or publicity rights, or breaches another agreement. These risks can include infringement damages, injunctions, takedown demands, lost revenue, settlement payments, and attorneys’ fees. In a copyright licensing agreement, the licensor should typically indemnify the licensee for claims that the licensor does not own or control the copyrighted material, lacks authority to grant the license, or supplied work that infringes another party’s rights. The licensee should typically indemnify the licensor for claims arising from the licensee’s unauthorized use, modification, distribution, failure to follow restrictions, or combination of the work with other materials. The indemnifying party may be required to defend the claim at its own expense, provide reasonable assistance, and pay covered losses, subject to notice, settlement approval, exclusions, and control of defense.
A well-structured copyright licensing agreement helps protect the copyright owner, gives the licensee reliable permission, and reduces disputes over scope, payment, ownership, territory, derivative works, and termination. A proper license agreement is specifically identifies the work, defines the rights granted, states the duration and territory, includes clear payment terms, preserves ownership, manages confidentiality, allocates risk, and requires written notice before key actions. For copyrighted material that is not in the public domain or covered by a valid exception, a written and signed copyright license is the safest path to lawful commercial use. Licenses are also critical tools for leveraging the important value and rights provided by copyrights.
© 2026 Sierra IP Law, PC. The information provided herein does not constitute legal advice, but merely conveys general information that may be beneficial to the public, and should not be viewed as a substitute for legal consultation in a particular case.
This article explains whether entrepreneurs and business owners can trademark a name, the requirements and process involved, and special considerations for personal and business names.
Can you trademark a name, like Donald or Johnson? Yes, under certain conditions. In U.S. trademark law, a name can become a trademark when it identifies the source of goods or services, and not merely the person or family behind the business. A trademark differentiates a business’s products or services from others, protects brand identity from misuse, and helps build customer trust. A name can function in that way if properly used and understood by the relevant consumers to be a trademark.
The answer is usually yes, but not every personal name, own name, business name, or famous person’s name can be registered as a trademark. Under trademark law, a trademark can be a word, name, symbol, logo, or design used in commerce to identify and distinguish goods or services, as provided by 15 U.S.C. § 1127. The key question is whether the name functions as a source identifier, meaning the trademark identifies a particular business, product line, or service, not merely the person behind it. In the case of a trademark application that includes a person's name, the United States Patent and Trademark Office (USPTO), in addition to determining whether the applied-for mark conflicts with a similar trademark, will review the trademark application to determine whether the mark is primarily merely a surname, and whether consent is required for a living person’s name. See 15 U.S.C. § 1052. If those issues are satisfied, a federal trademark registration may be issued and provide legal protection and stronger trademark rights.
A key distinction in this area of trademark law is that given names and surnames are not treated the same. A first name can often be registered as a trademark without proof of acquired distinctiveness if it is used in commerce to identify goods or services and functions as a source identifier; in other words, the USPTO does not refuse a mark merely because it is a given name. A personal name such as a first name may still face ordinary trademark protection issues, including likelihood of confusion, descriptiveness, and consent if the mark identifies a living person. See 15 U.S.C. § 1052(c).
By contrast, under 15 U.S.C. § 1052(e)(4), a mark that is primarily merely a surname may be refused registration on the principal register unless the applicant proves acquired distinctiveness under 15 U.S.C. § 1052(f). The policy of treating last names as non-distinctive marks is due to the fact that surnames are shared by many people, so trademark rules are cautious about giving one business exclusive federal registration rights in a surname. The surname inquiry asks whether the mark’s primary significance to purchasers is a surname. Courts and the Trademark Office consider the rarity of the surname, whether anyone connected with the applicant has that surname, whether the term has another recognized meaning, and whether added wording or design creates a separate commercial impression. See In re Etablissements Darty et Fils, 759 F.2d 15 (Fed. Cir. 1985); In re Hutchinson Technology Inc., 852 F.2d 552 (Fed. Cir. 1988). Thus, JOHN may face different registrability issues than JOHNSON: the first is not refused merely because it is a given name, while the last name may need secondary meaning.
The courts and USPTO are primarily interested in avoiding consumer confusion by ensuring that trademarks (whether a surname, a fanciful name for a brand, or some other type of mark) are distinctive. Surnames are a special case because they are shared by many people and potentially may be used by many business owners (e.g., family-named businesses). The treatment of surnames as weak marks is to prevent the potential confusion that can arise from multiple businesses using the same surname.
In the case that the surname is denied registration on the principal register, it may be alternatively registered on the supplemental register. A supplemental registration provides a trademark registration, but without many of the presumptions and rights provided by a principal registration. The registrant can later re-apply for the principal register once the registrant can show that the mark has acquired distinctiveness amongst relevant consumers.
To register a living person’s name, portrait, signature, likeness, nickname, or pseudonym, the applicant generally must submit written consent if the mark identifies a living individual. The Lanham Act bars registration of a name, portrait, or signature identifying a particular living individual without written consent under 15 U.S.C. § 1052(c). This rule can apply even when the applicant has a legitimate business reason to use the personal name, including where a founder, designer, performer, or public-facing employee wants to use his or her name as a brand. If the mark includes a living person’s name, the applicant should include a consent statement or submit one during examination. The USPTO explains that consent must include a statement consenting to registration, the living person’s signature, and the date. Without consent, the application may be refused.
Federal trademark law gives additional protection to celebrity names and a famous person’s identity because consumers may assume that a mark using a famous person’s name, nickname, persona, or other identifying reference was approved, sponsored, or licensed by that person. Under 15 U.S.C. § 1052(a), a trademark application may be refused if the proposed mark falsely suggests a connection with a person, whether living or dead. This protection can apply even where the celebrity has not used his or her name as a trademark for competing goods or services. The key question is whether the name or reference points uniquely and unmistakably to the famous person and whether consumers would presume a connection without permission.
In In re Sauer, 27 U.S.P.Q.2d 1073 (TTAB 1993), the Trademark Trial and Appeal Board refused BO BALL because the evidence showed that purchasers would associate the mark with Bo Jackson, whose nickname “Bo” and athletic fame gave the phrase a recognized meaning tied to him. Because Sauer lacked consent, registration was refused. In Vidal v. Elster, 602 U.S. 286 (2024), the Supreme Court upheld the Lanham Act’s living-person “names clause,” confirming that Congress may require consent before another party obtains federal registration of a living person’s name.
A personal name will not be approved as a trademark if it closely resembles an existing trademark for related goods or services. The likelihood of confusion test asks whether consumers might believe two businesses are connected. 15 U.S.C. § 1052(d) authorizes refusal where a mark resembles a registered or previously used mark in a way likely to cause confusion. The key case is In re E.I. du Pont de Nemours & Co., 476 F.2d 1357 (C.C.P.A. 1973), whose factors are used by examiners and the appeal board. There is no mechanical test, and each case depends on its facts.
Trademarking a name involves a multi-step federal process through the USPTO. Before filing, a trademark search should be performed, including a search of the USPTO database for similar names. A new trademark application should identify the owner, mark, goods or services, filing basis, specimen if based on actual use, and any required consent statement. Current USPTO fees are generally $350 per class for a base electronic application. Current USPTO data shows average time to registration or abandonment around 9.9 months, while the USPTO says the overall process usually takes 12–18 months. Federal registration provides legal protection, a presumption of ownership, and nationwide protection subject to prior users and registration limits. See 15 U.S.C. §§ 1057, 1072, and 1115(a).
So, can you trademark a name? Yes, if the name functions as a trademark by identifying the source of specific goods or services, is distinctive enough for trademark protection, and does not create a likelihood of confusion with a similar trademark. Business owners should choose a name that supports a clear brand identity, vet the name before filing by performing a trademark search and analysis, and confirm that the mark will be properly used in commerce. However, it must be noted that the USPTO will likely treat a surname as a weak mark and require a showing of acquired distinctiveness before granting a registration on the principal register. When a name is successfully registered, the federal registration can strengthen trademark rights, provide nationwide protection, enable robust trademark enforcement against infringement, and protect the customer trust built into the brand.
If you need assistance with establishing trademark rights in a name or other trademark matters, contact our office for a consultation with one of our experienced trademark attorneys.
© 2026 Sierra IP Law, PC. The information provided herein does not constitute legal advice, but merely conveys general information that may be beneficial to the public, and should not be viewed as a substitute for legal consultation in a particular case.
The Invention Secrecy Act of 1951 is a federal patent law that allows the government to keep certain inventions secret when publication or disclosure could be detrimental to national security. Sensitive technologies that relate to weaponry, cybersecurity and encryption, or other technologies that have potential national security implications may be subject to a secrecy order and prevented from being patented. In such cases, a United States patent application may be filed, examined, and even found allowable, but the patent therefor is not granted because of the risk the technology creates. This article covers the purpose, process, consequences, and practical implications of the Invention Secrecy Act of 1951, explaining how secrecy orders may affect your patent rights and commercialization plans.
The Invention Secrecy Act of 1951 is codified at 35 U.S.C. §§ 181–188 and creates a national security exception to the ordinary United States patent system. Under 35 U.S.C. § 181, when the Atomic Energy Commission, the Secretary of Defense, or a chief officer of a government designated defense agency determines that publication or disclosure of such invention, or the grant of a patent, would be detrimental to national security, that interested government agency must notify the Commissioner of Patents. The Commissioner will then issue a secrecy order, keep the patent application secret, and withhold publication and grant of the patent until the secrecy order is removed. In practical terms, the Act allows the government to delay patent rights and public disclosure when national security reasons outweigh normal patent-law transparency, while notifying the applicant thereof and preserving statutory procedures for later review.
The Act is meant to protect military, intelligence, atomic-energy, and other defense-sensitive technologies when public disclosure could create national security risks. Under 35 U.S.C. § 181, the legal trigger is not whether an invention is valuable, controversial, or commercially disruptive, but whether publication or disclosure would be detrimental to national security interests. The Invention Secrecy Act is not designed to shield existing industries from competition, nor to prevent new technologies from entering the market merely because they may disrupt such industries. Its purpose is governmental security, not economic protectionism.
The origins of U.S. invention secrecy trace to the 1910s, when Congress first authorized restrictions on patent disclosures during wartime. The practice expanded dramatically during World War II, when secrecy orders became a tool for controlling inventions relevant to weapons systems, communications, aviation, and the classified development of nuclear weapons. The Invention Secrecy Act of 1951 made this authority permanent, allowing secrecy orders to continue outside wartime where the national interest requires secrecy. In practice, the Act reflects a tension between two policies: encouraging inventors to disclose inventions through the patent system and preventing disclosure that could harm national security.
The screening process under the Invention Secrecy Act is usually a two-stage review. First, the USPTO reviews each new patent application filed (non-provisional and provisional applications) for subject matter that may implicate national security, including military, intelligence, nuclear, communications, encryption, aerospace, or other dual-use technologies. This initial review does not necessarily mean the invention is classified or that the applicant has done anything wrong; it means the application contains technical material that may warrant government review before publication.
Second, the USPTO forwards the flagged application to an interested government agency or defense agency with responsibility for the relevant technology. Under 35 U.S.C. § 181, the agency evaluates whether disclosure or publication of the invention would be detrimental to national security. The statute also contemplates controls over handling, including a dated acknowledgment by reviewing officials. If the agency makes the required determination, it recommends that the USPTO issue a secrecy order. The Commissioner then orders the invention kept secret and withholds publication or issuance of the patent. This means a commercially valuable patent application can move from ordinary patent examination into a restricted process where outside disclosure, licensing, fundraising, and commercialization may be sharply limited.
Under 35 U.S.C. § 181, the initial security decision is not made by the ordinary patent examiner. The USPTO screens the patent application, but the substantive national security judgment is made by the head of the interested government agency reviewing the technology. Section 181 refers to the Atomic Energy Commission, the Secretary of a Defense, or such other chief officer of some other department or agency designated by the President as a defense agency of the United States. In practical terms, the relevant chief officers decide whether disclosure of such invention to the general public would be detrimental to national security or whether the national interest requires continued secrecy.
The statute also imposes procedural safeguards. Each reviewer who receives the application must sign a dated acknowledgment, creating a record of access to sensitive patent material. Recent public data identify secrecy order sponsors as including the Army, Navy, Air Force, DOE, NSA, DTSA, and other defense-related agencies. The key point is that the secrecy order decision is driven by specialized national security agencies, not by ordinary commercial concerns or the concern that an invention might disrupt existing industries.
A secrecy order can place a patent application in a sealed condition, restrict access to material information, and keep the patent withheld even when the claims are otherwise allowable. Under 35 U.S.C. § 181, the USPTO must withhold publication and grant of a patent when an interested government agency determines that disclosure of the invention may be detrimental to national security. USPTO rules also require the applicant to continue prosecuting the application while the order remains in effect, but if the application is otherwise ready for allowance, the application is suspended until the secrecy order is removed. See 37 C.F.R. § 5.3.
In practical terms, the order can freeze the commercial usage of the invention. The applicant thereof, inventors, assignees, investors, employees, contractors, consultants, manufacturers, and potential licensees may be barred from receiving or using information about the restricted idea unless disclosure is authorized. That can prevent fundraising, product testing, licensing, manufacturing, publication, foreign patent filings, and ordinary commercialization. Also, while a secrecy order is active, inventors may be unable to sell, license, market, commercialize, or develop the technology with outsiders if doing so would require unauthorized disclosure.
A violation of secrecy orders under the Invention Secrecy Act can have severe consequences for inventors and businesses. Under 35 U.S.C. § 182, if a patent application subject to a secrecy order is published, disclosed, or filed abroad without proper authorization, the Commissioner of Patents may hold the invention abandoned. That abandonment is treated as occurring at the time of the violation and can forfeit all claims against the United States based on such invention, including potential compensation claims.
Under 35 U.S.C. § 186, a person who, with knowledge of the order and without authorization, willfully publishes or discloses the invention or material information about it may face criminal penalties. The same penalty applies to unauthorized Patent Cooperation Treaty or foreign patent application filing in violation of 35 U.S.C. § 184. Upon conviction, the violator may be fined up to $10,000, imprisoned for up to two years, or both. For startups, this risk can eliminate development and commercialization of their technology.
A peacetime secrecy order under the Invention Secrecy Act may last for a significant period. Under 35 U.S.C. § 181, an initial order may last no more than one year, but the Commissioner must renew the order at the end thereof, or at the end of any renewal period, for additional periods of one year when the interested agency gives notice that it has made an affirmative determination that the national interest continues to require secrecy. In practical terms, a patent application can remain pending, unpublished, and unavailable for normal commercialization year after year, even outside a declared war.
The statute also creates longer rules for extraordinary conditions. During war, the order remains effective for the duration of hostilities and one year after hostilities cease. If an order is in effect or issued during a national emergency declared by the President, it remains effective for the duration of the national emergency and six months afterward. The Commissioner may rescind the secrecy order only after notification from the relevant agency or chief officers that disclosure is no longer deemed detrimental to national security. A “temporary” secrecy order can function like an indefinite patent hold, delaying investment, licensing, enforcement, and market entry.
The law permits inventors to seek just compensation when a secrecy order causes economic losses or when the government uses the restricted technology. Under 35 U.S.C. § 183, an applicant whose patent is withheld may apply to the relevant agency for compensation based on damage from secrecy and any government use of the invention. However, compensation is not automatic. The inventor must make a proper showing that the secrecy order caused actual loss, which can be difficult because the inventor is often prohibited from disclosing, marketing, licensing, or commercializing the invention. If the agency does not agree to a full settlement, it may pay an amount not exceeding 75 percent of what the agency head considers just compensation. The inventor may then bring suit in the Court of Federal Claims or an appropriate district court to recover the balance. This framework recognizes a protected property interest, but it also leaves inventors with significant proof and valuation challenges.
Inventors face a practical proof problem: to show they suffered harm from secrecy, they often need market evidence, customers, licensees, expert analysis, or investment discussions. However, a secrecy order creates a Catch-22 because the invention cannot be freely disclosed and market evidence cannot be established. In Constant v. United States, 617 F.2d 239 (1980), the Court of Claims held that allegations of lost financing, lost licensing opportunities, and blocked demonstrations could properly state a claim under 35 U.S.C. § 183. But after trial, plaintiff was denied recovery because the damages evidence was speculative. In Hornback v. United States, 16 F.3d 422 (Fed. Cir. 1994), the court held § 183, not a Fifth Amendment taking theory, was the exclusive remedy for secrecy-order claims and actual damages, especially where the patent remained withheld from public issuance.
Secrecy orders have increasingly affected private technologies, not just traditional military inventions. For companies developing software, communications systems, sensors, aerospace tools, cryptography, energy, semiconductors, or public health technologies that may have defense implications, the Invention Secrecy Act can create serious business uncertainty. The Act may alter the basic patent bargain: inventors disclose inventions to obtain temporary exclusivity, but the government may take the disclosure while withholding commercial patent rights. That means a company may lose the ability to publish, license, sell, raise investment around, or openly develop a technology while the secrecy order remains in place. The risk is especially important for startups and research-driven businesses that depend on patent assets to attract funding or strategic partners. Even when compensation may theoretically be available, proving market value and lost opportunities can be difficult because the invention itself cannot be freely disclosed. As a result, innovators working in sensitive technical fields should consider secrecy-order risk early in their patent filing, funding, commercialization, and foreign filing strategies.
The Invention Secrecy Act of 1951 remains an important but often overlooked part of U.S. patent law. It gives the government broad authority to restrict inventions for national security purposes, require the applicant to maintain secrecy, delay patent issuance, and control disclosure for such period that national security interests are affected. At the same time, it provides limited compensation and appeal mechanisms. If a technology has military, intelligence, atomic-energy, or dual-use implications, patent strategy should account for the possibility that a secrecy order might be applied to the corresponding patent application.
If you have concerns about the Invention Secrecy Act or other intellectual property matters, please contact our office for a consultation with our skilled patent attorneys.
© 2026 Sierra IP Law, PC. The information provided herein does not constitute legal advice, but merely conveys general information that may be beneficial to the public, and should not be viewed as a substitute for legal consultation in a particular case.
Patent valuation is the process of estimating the economic value of patents, patent portfolios, and related intellectual property rights. The process translates legal protection into practical business information for licensing, selling, patent acquisition, fundraising, mergers, joint venture planning, financial reporting, transfer pricing, and litigation. Because patents are intangible assets and may be assigned, licensed, pledged, or sold, their value can affect a company’s assets, negotiations, and investment strategy. Different purposes may require different methods, including the cost approach, income based method, market approach, Discounted Cash Flow, Relief-from-Royalty, or option-based analysis. Patent valuation is increasingly important as companies rely more on intangible assets, including intellectual property. This article explains how valuing patents works and why understanding patent value helps companies make informed decisions about their IP assets.
Patent valuation measures more than the money required to obtain a patent. It estimates the patent value created by exclusive rights in a patented invention, including the legal right to prevent others from making, using, selling, offering for sale, or importing the invention. It also evaluates the underlying invention’s expected business impact, such as revenue opportunities, cost savings, market leverage, licensing potential, and contribution to competitive advantage. Under 35 U.S.C. § 261, patents have attributes of personal property and are assignable, meaning they can be treated as intangible assets within a company’s assets. As a result, patents may be licensed, sold, pledged as collateral, contributed to a joint venture, or included in merger, acquisition, or financing transactions. A useful valuation therefore considers both legal enforceability and commercial usefulness, converting intellectual property rights into an estimated monetary value that business owners, investors, and buyers can use in negotiations and strategic planning.
Patent valuation helps companies translate intellectual property rights into practical business terms. In licensing and sales, it establishes a baseline for royalty rates and helps each side negotiate from a reasoned estimate rather than guesswork. In mergers and acquisitions, valuing patents helps determine fair purchase prices by identifying the contribution of intangible assets, including patented products, exclusive rights, and potential future cash flows. For fundraising, patents may support collateral for bank loans or strengthen a pitch for venture capital investment by showing that innovation has measurable patent value. Patent valuation also guides commercialization decisions, such as whether to manufacture, license, sell, enforce, or contribute a patent to a joint venture. Understanding patent economics helps define trading conditions when intellectual property rights are transferred, licensed, or bundled with technology assets, and it can reveal when companies are likely to overvalue patents or overlook low-value assets that should be sold or abandoned.
When an individual develops an innovation and a patent is granted, the legal value is in the exclusionary rights of the patent, including the ability to prevent others from making, using, selling, offering to sell, or importing the patented invention, as provided in 35 U.S.C. § 154(a)(1). In patent valuation, that right is a core driver of patent value because it defines the scope of commercial protection and the period during which the owner may capture patent licensing revenue, market share, or cost savings. U.S. utility patent term generally runs from issuance to 20 years from the relevant filing date, subject to fees and adjustments under 35 U.S.C. § 154. The type of patent (e.g., utility patents, design patents, plant patents, or utility models) also affects value because protection periods, claim scope, enforceability, examination standards, and internationalization possibilities differ. Thus, understanding patent rights requires reviewing ownership, priority, prosecution history, maintenance status, and remaining protection time before applying valuation methods.
Evaluating patents requires both legal and business analysis because patent value depends on more than the existence of a granted patent. The legal strength of a patent is found in:
A patent with narrow claims, unclear terminology, weak prior-art distinctions, or potential validity issues may have a lower value even if the underlying invention is promising.
Market potential is equally important. This factor examines the addressable market size, expected revenue growth, industry demand, and whether customers are likely to pay for patented products or services. The competitive landscape assesses the existence of competitors, substitute technologies, barriers to entry, and the possibility of market share gains. A patent that supports a durable competitive advantage generally has higher patent value.
When assessing patent value, commercialization status also matters: is the technology currently in use, licensed, sold, or producing profit? Technological validation is another key issue because investors and buyers want evidence that the invention works in practice. Patents lacking practical viability increase perceived investor risk and can significantly lower value, even when the legal rights appear strong.
The jurisdiction of the patent rights affects patent valuation because market potential, legal security, enforcement reliability, and access to financing vary by jurisdiction. A patent covering a large commercial market, or a country with strong remedies for infringement, may have greater patent value than protection in a smaller or less predictable market. The current state of the registration cycle also matters. A pending application may support business planning, fundraising, or patent acquisition, but it usually carries more uncertainty than an allowed application or granted patent. Patents approved after substantive patent examination may be viewed as stronger because the patent claims have survived closer review. Remaining protection time is equally critical: under 35 U.S.C. § 154, many U.S. utility patents generally expire 20 years from the relevant filing date, so fewer remaining years means less time to exploit the patented invention exclusively.
The cost approach estimates patent value by looking at the costs incurred to create, file, prosecute, maintain, or replace the asset. The cost approach estimates the value based on the costs incurred to develop the patent, including research and development expenses. In patent valuation, this method is often useful when the patented invention is early in development, has not yet generated revenue, or lacks reliable market transactions for comparable patents. The replacement cost method asks what money would be required to acquire or develop comparable IP with similar utility, while the reproduction method asks what it would cost to recreate the same technology in its current state. These costs may include research and development, engineering, testing, prototype development, patent drafting, USPTO filing fees, prosecution costs, patent maintenance fees, and related legal fees.
The key limitation is that costs do not necessarily equal patent value. A company may spend heavily on an invention that has little market potential, weak claims, or limited commercial use, causing the cost approach to overvalue patents. Conversely, a relatively inexpensive innovation may create substantial competitive advantage or generate significant future cash flows, meaning the method may undervalue breakthrough inventions. The cost method can be helpful for early-stage assets, but it does not directly measure future economic value, market demand, licensing potential, or the income that the patent may ultimately produce.
The income-based method is one of the most common approaches to patent valuation because it focuses on the economic benefits the patent is expected to produce. The income approach values a patent based on the present value of expected future cash flows that the patent will generate. Instead of asking only what the patented invention cost to develop, this method evaluates the future cash flows attributable to the patent, including expected licensing revenue, cost savings, premium pricing, increased market share, or additional sales of patented products.
A Discounted Cash Flow (DCF) analysis estimates patent value by projecting the specific cash flows that the patent is expected to generate during its remaining useful life. These cash flows may come from royalty income, increased sales of patented products, premium pricing, cost savings, or avoided licensing payments. The forecast should account for expected market adoption, commercialization timing, remaining patent term, potential design-arounds, and the likelihood that the patent can be enforced if infringement occurs. After the projected cash flows are identified, they are discounted to present value using a risk-adjusted discount rate. That discount rate should reflect commercial uncertainty, technology risk, litigation risk, competitive alternatives, regulatory or manufacturing barriers, and the legal strength of the patent rights. Because small changes in revenue assumptions, growth rates, or the discount rate can materially change the valuation, DCF analysis is usually tested through sensitivity scenarios to produce a more reliable valuation range.
The income approach values intellectual property based on expected future cash flows discounted to present value, but the analysis is highly sensitive to assumptions about revenues, timing, risks, market adoption, and remaining useful life. For that reason, companies should carefully separate income caused by the patent from income caused by branding, distribution, manufacturing capacity, or other business assets. When performed carefully, the income based method can provide a practical estimate of patent value for licensing, acquisition, investment, and strategic decision-making.
Relief-from-Royalty is an income based method of patent valuation that calculates the royalty payments a company avoids by owning the patent instead of licensing it from another owner. The basic valuation calculation starts by identifying the patented products, services, or technology that generate income, estimating expected revenue over the remaining protection period, and applying a supportable royalty rate. That rate is usually informed by comparable royalty data, similar licenses, industry norms, bargaining strength, exclusivity, territory, field of use, and the legal strength of the patent. After estimating the avoided royalty stream, the analysis typically adjusts for taxes or expenses and discounts the projected cash flows to present value using an appropriate discount rate.
This method is especially useful when the patented invention is already commercialized or can be tied to specific income. For example, if a patented component drives sales of a product, the analysis must determine how much of the revenue is actually attributable to the patent rather than branding, distribution, manufacturing quality, or other assets. Relief-from-Royalty can provide a practical estimate of patent value, but it depends heavily on accurate revenue forecasts, reliable comparable royalty data, and careful apportionment to avoid overstating the monetary value of the patent.
The market approach determines a patent’s value by comparing it to similar patents, comparable patents, similar property, patent prices, licenses, or sale transactions in an active market. In practice, this method asks what real buyers, licensees, or investors have paid for intellectual property rights with comparable legal, technological, and commercial characteristics. It is strongest when transactions involve similar patents, similar territories, similar fields of use, similar remaining lives, and comparable levels of commercialization. For example, a licensed patent covering a validated medical device in the United States may be a more reliable benchmark for another U.S. medical device patent than a software patent licensed in a different country or industry.
Market comparables can be powerful because they are grounded in actual transactions rather than purely theoretical assumptions. However, they can also be difficult to apply because IP is unique, deal terms are often confidential, and sufficiently similar comparables may be scarce. Reported patent prices may also reflect bundled assets, cross-licenses, litigation settlements, technical know-how, or strategic motivations that are not visible from the headline number. As a result, the market approach usually requires careful adjustments for patent strength, scope, enforceability, remaining protection time, revenue potential, and competitive advantage.
Qualitative methods are useful when patent valuation cannot rely solely on historical cash flows, comparable transactions, or patent prices. These methods typically involve scoring legal strength, technology readiness, market demand, competitive advantage, commercialization status, freedom-to-operate risk, and the remaining protection period. For example, a patent with broad, enforceable claims, strong technological validation, and clear market potential may receive a higher qualitative rating than a patent covering an unproven technology in a crowded field. However, qualitative methods depend heavily on subjective assumptions, so companies should document the factors, weighting, and evidence used in the analysis.
Option-based methods are often used when the patented invention is early-stage or when future business outcomes remain uncertain. An option-based method for patent valuation applies financial option pricing models to assess the value of the rights associated with a patent. Models such as Black-Scholes-style approaches, commonly used for stock options, treat patent rights like a call option: the patent owner has the right, but not the obligation, to invest later if the market improves or development milestones are met. In patent valuation, this approach may capture value that traditional income based method calculations miss, especially where future cash flows are speculative. Real options analysis is a way to measure strategic flexibility in uncertain technology development, making it helpful for startups, investors, and companies evaluating emerging innovation.
Patent valuation provides a financial basis for claiming damages in infringement litigation and for assessing the business risk of a patent conflict before filing suit or negotiating settlement. Under 35 U.S.C. § 284, damages must be adequate to compensate for infringement and cannot be less than a reasonable royalty for the infringing use. Under 35 U.S.C. § 285, courts may award legal fees in exceptional cases, which can materially affect the economic analysis of litigation.
Patent damages often fall into two categories: lost profits, where the patent owner proves it would have made sales or profits but for infringement, and reasonable royalty, where damages are measured by a hypothetical license between willing parties. In Panduit Corp. v. Stahlin Bros. Fibre Works, Inc., 575 F.2d 1152 (6th Cir. 1978), the 6th Circuit Court of Appeals articulated the familiar lost-profits framework: demand for the patented product, absence of acceptable non-infringing substitutes, capacity to meet demand, and the amount of profit the patentee would have made. Rite-Hite Corp. v. Kelley Co., 56 F.3d 1538 (Fed. Cir. 1995) further confirmed that lost profits require “but-for” causation and may account for market realities where infringement diverts sales.
For reasonable royalty, Georgia-Pacific Corp. v. U.S. Plywood Corp., 318 F. Supp. 1116 (S.D.N.Y. 1970) provides the traditional factors for reconstructing a hypothetical negotiation. Later Federal Circuit cases delineated evidentiary standards that require a disciplined approach to assigning royalty value. Lucent Techs., Inc. v. Gateway, Inc., 580 F.3d 1301 (Fed. Cir. 2009) vacated a royalty award where licenses and the royalty base were not sufficiently tied to the patented feature. Uniloc USA, Inc. v. Microsoft Corp., 632 F.3d 1292 (Fed. Cir. 2011) rejected the 25-percent rule and cautioned against using the entire market value of accused products unless the patented feature drives demand. A defensible valuation must take into account market demand, non-infringing alternatives, accused-product revenue, and the patented invention’s incremental contribution.
Strategic IP portfolio management uses valuation to identify patents for abandonment, sale, or non-renewal, directing investment toward those patents with the greatest return and potential. Patent valuation can also reveal where a company’s assets are concentrated, which patents support key products, and which intellectual property rights may create leverage in licensing, patent acquisition, fundraising, or a joint venture. For accounting purposes, patent valuation supports financial reporting for identifiable intangible assets, including purchase price allocation after mergers and acquisitions and impairment analysis when projected cash flows decline. In tax planning, valuation is important for transfer pricing regulations governing controlled transfers of intangibles, including patents, between related companies. Because accounting, tax, litigation, and transaction value may each require different approaches, companies should define the valuation purpose before selecting methods. This helps investors, companies, and inventors compare estimated outcomes and avoid overvaluing patents based on inconsistent assumptions.
Valuing patents is not a single formula; it is a process that combines law, technology, market evidence, income forecasts, development costs, and subjective assumptions. The best analysis uses different methods, cost, income, market, and qualitative or option-based methods, to determine true worth for the specific business purpose. Understanding patent valuation establishes intellectual property as a strategic asset that can support protection, commercialization, financing, transactions, and competitive advantage.
© 2026 Sierra IP Law, PC. The information provided herein does not constitute legal advice, but merely conveys general information that may be beneficial to the public, and should not be viewed as a substitute for legal consultation in a particular case.
This page explains trademark consent agreements, their role in trademark registration, and how they differ from coexistence agreements. A trademark consent agreement can be especially important when an examining attorney refuses an application based on a likelihood of confusion with a previously registered mark.
A trademark consent agreement is a contract where a trademark owner allows another party to use and register a similar trademark. Businesses often use a consent agreement when the United States Patent and Trademark Office (USPTO) refuses an applied-for mark because it resembles a previously registered mark. Under Lanham Act § 2(d), the USPTO may refuse trademark registration where a mark is likely to cause mistake, deception, or consumer confusion. See 15 U.S.C. § 1052(d).
A consent agreement can be useful when an examining attorney issues a likelihood of confusion refusal under Lanham Act § 2(d) because the applied-for mark appears too similar to a previously registered mark for related goods or services. In that situation, the applicant may submit a trademark consent agreement to support registration by showing that the applicant and the other party to the agreement (the owner of the cited trademark) have assessed the marketplace and believe confusion is unlikely despite concurrent use of the marks by the parties. The Trademark Manual of Examining Procedure (TMEP) recognizes that an applicant may submit a consent agreement either after a refusal or in anticipation of a refusal. See TMEP § 1207.01(d)(viii). To be persuasive, the agreement should do more than grant permission. It should explain the parties’ respective marks, goods and services, trade channels, customer bases, and any restrictions designed to prevent confusion. Evidence that the parties have coexisted without actual confusion can further strengthen the applicant’s response.
A trademark coexistence agreement is a more comprehensive arrangement that provides greater protection than a simple consent agreement, often including limitations on locations, industries, and marketing methods. A simple consent agreement typically focuses on one narrow issue: the senior user consents to the junior user’s trademark use and registration, usually to help overcome a USPTO likelihood-of-confusion refusal. It may confirm that the parties believe confusion is unlikely, but if it contains few operational limits, the Trademark Office may give it less weight.
A trademark coexistence agreement is a comprehensive agreement between the parties that defines the parties' uses of the respective marks in a way that allows the parties to peacefully coexist in the marketplace without consumer confusion. It establishes rules for long-term coexistence, such as who may use particular domain names, social media handles, advertising formats, geographic market restrictions, restrictions on particular goods or services, and restrictions on trade channels. These coexistence agreements are common when two businesses operate in related but distinct sectors and both want federal protection without disrupting legitimate brand growth. A well-drafted agreement may also address future expansion, trademark enforcement, customer inquiries, and procedures for resolving actual confusion. In practice, coexistence agreements usually provide stronger business certainty than a bare consent.
Coexistence and consent agreements should do more than record permission. They should identify the respective marks, the goods and services covered, each party’s ownership position, any additional marks, and the scope of permitted trademark use. The agreement should also state whether the parties agree not to challenge each other’s rights, oppose future applications, or interfere with registration, subject to defined limits. A well-drafted trademark coexistence agreement typically addresses territories, domain names, advertising, social media handles, trade channels, customer bases, and procedures for handling actual confusion if it arises. These provisions can create legal certainty for expansion, particularly where one party has greater bargaining power or the senior user wants to preserve priority. Still, the agreement must protect the public interest in avoiding confusion. The USPTO and courts may discount private consent if the arrangement leaves consumers exposed to materially similar marks in the same channels.
The USPTO gives meaningful weight to consent agreements because the parties typically understand their markets, customers, trade channels, pricing, branding, and day-to-day commercial realities better than the USPTO can from an application record alone. The Federal Circuit has said that consent agreements may carry great weight because the parties are often in the best position to evaluate whether simultaneous use of their respective marks is likely to cause consumer confusion. In In re Four Seasons Hotels Ltd., 987 F.2d 1565 (Fed. Cir. 1993), the court credited a consent agreement that included detailed restrictions on use, location, and cooperation to address confusion.
That said, the USPTO does not automatically accept every consent agreement. The agreement is more persuasive when it contains a reasoned assessment of the relevant factors, such as differences in the parties’ services, separate trade channels, distinct customers, and the absence of actual confusion. It should also include practical provisions requiring the parties to take commercially reasonable steps to avoid confusion if problems arise. A detailed agreement with real evidentiary support is more likely to overcome a likelihood of confusion refusal than a short, naked consent that merely states that one party consents to trademark registration.
The USPTO gives more weight to agreements that contain a reasoned assessment of why confusion is unlikely, rather than a bare statement that the parties consent. A persuasive trademark consent agreement should explain the marketplace facts that reduce the likelihood of confusion, including how the respective marks are used, the nature of the goods and services, and whether customers are likely to encounter the brands in the same channels. Strong provisions include a clear indication of separate trade channels, restrictions on the parties’ fields of use, different marketing methods, limitations on geography or customer types, and procedures for handling mistaken inquiries.
Evidence can also matter. The parties can identify any period of simultaneous use, explain whether there has been actual confusion, and provide factual support for their conclusion that confusion is unlikely. The agreement should also require the parties to take commercially reasonable steps to prevent confusion and avoid confusion if problems arise, such as modifying packaging, clarifying website language, training sales staff, or redirecting misdirected communications. The more detailed and practical the restrictions are, the more likely an examining attorney will view the agreement as meaningful evidence rather than a naked consent.
A naked consent, a consent agreement that merely grants permission, or simply states that confusion is unlikely, is usually given little weight in a likelihood of confusion analysis. The USPTO does not reject consent agreements because they are private contracts. The USPTO must still protect consumers, so the agreement should “show the work.” In In re E.I. du Pont de Nemours & Co., 476 F.2d 1357 (C.C.P.A. 1973), the court distinguished bare consent from more detailed agreements, which may receive substantial weight. In In re Mastic Inc., 829 F.2d 1114 (Fed. Cir. 1987), the Federal Circuit held that a consent is stronger when “clothed” with specific arrangements to avoid confusion, such as limits on products, marketing, or trade channels. In In re Donnay Int’l, S.A., 31 USPQ2d 1953, 1956 (TTAB 1994), the TTAB explained that more evidentiary support for such conclusions produces more weight.
That rule drove In re Ye Mystic Krewe of Gasparilla, 2025 USPQ2d 1291 (TTAB 2025). The TTAB found multiple failings: the marks were highly similar, the goods overlapped, and the agreement did not require separate trade channels or restrict fields of use. Its actual confusion provision required only commercially reasonable steps after confusion arose, so the consent helped only slightly and did not overcome the refusal.
A strong agreement should do more than state that the parties consent to simultaneous use of their marks. It should address how the brands will appear in packaging, websites, invoices, apps, advertising, customer portals, and customer-facing support pages. The agreement should also define permitted goods and services, territories, trade channels, domain names, social media handles, logo usage, and any required disclaimers or house marks. If customer confusion occurs, the agreement should require commercially reasonable steps to investigate and resolve it. A detailed agreement gives the USPTO stronger evidence that confusion is unlikely.
If a likelihood of confusion refusal continues after the applicant submits a trademark consent agreement, the applicant may appeal to the Trademark Trial and Appeal Board (TTAB), the USPTO’s appeal board for ex parte trademark refusals after a final examining attorney decision. 15 U.S.C. § 1070 authorizes trademark appeals from final examiner decisions. Importantly, the appeal record should generally be complete before appeal, so consent evidence should be developed early, not saved for later TTAB proceedings.
In appeal practice, a consent agreement is powerful evidence, but not an automatic win. In In re Four Seasons Hotels Ltd., the Federal Circuit reversed a refusal involving FOUR SEASONS BILTMORE and THE BILTMORE LOS ANGELES because the parties had long coexisted and adopted concrete restrictions, including location-specific use and cooperation if confusion arose. By contrast, in Gasparilla, the TTAB gave little weight to a consent agreement involving highly similar GASPARILLA marks because it lacked meaningful limits on trade channels, fields of use, and evidence of no actual confusion.
A trademark consent strategy can reduce a potential risk and help a business register a mark, but permission alone is not enough. The best agreement explains why the parties’ marks can coexist, restricts use where needed, includes evidence, and gives the USPTO and any court practical reasons to trust the parties’ assessment of likelihood and confusion.
If you need assistance with a potential trademark consent situation or other intellectual property matter, please contact our office for a consultation with one of our experienced trademark attorneys.
© 2026 Sierra IP Law, PC. The information provided herein does not constitute legal advice, but merely conveys general information that may be beneficial to the public, and should not be viewed as a substitute for legal consultation in a particular case.
This page explains what trade secrets are, provides practical trade secret examples, summarizes the legal definitions that apply under trade secret law, and outlines basic protection strategies for keeping valuable business information confidential. It is intended for business owners, legal professionals, students, and others who want to understand how trade secret protection works in real-world settings.
A trade secret is a type of intellectual property that consists of information, such as a formula or process, that derives economic value from not being generally known or readily ascertainable, and is subject to reasonable efforts to maintain its secrecy.
In other words, a trade secret is business information that stays valuable because competitors do not know it. For many businesses, trade secrets play a crucial role in protecting intellectual property, preserving a competitive advantage, and keeping a long-term competitive edge. Trade secrets can protect proprietary information indefinitely if they remain secret. Unlike patents, trade secret protection does not require public disclosure, examination, registration, renewal, or formal registration costs. Trade secrets are not applied for or registered, and that protection can be unlimited if legal secrecy requirements are met.
That makes trade secrets attractive for a comprehensive IP strategy, especially for companies that continuously refine proprietary systems, software, formulas, or manufacturing processes.
Under federal trade secret law, a trade secret includes financial, business, scientific, technical, economic, or engineering information, such as formulas, methods, techniques, processes, programs, or codes, if the owner takes reasonable efforts to keep the information secret and the information has independent economic value because it is not generally unknown or readily ascertainable. See 18 U.S.C. § 1839(3).
In plain English, a trade secret is commercially valuable confidential information that gives your business an advantage because competitors do not have it. Common trade secret examples include:
For example, a food company may treat a sauce recipe, spice blend, or production method as a trade secret if the exact ingredients, measurements, and preparation steps are not publicly disclosed.
A technology company may protect proprietary systems, algorithms, training data, or code that improve search results, recommendations, automation, or user engagement. A manufacturer may protect a process that lowers costs, improves durability, increases speed, or produces a better product than competitors can easily replicate.
The key point is that legal protection does not apply merely because the "trade secret" information is useful. The information must derive value from being secret. A customer list copied from a public directory usually will not qualify. But a curated list containing customer needs, purchasing history, pricing preferences, renewal dates, decision-makers, and relationship notes may qualify because it reflects proprietary knowledge developed through time, expense, and business experience.
Trade secrets also differ from patent protection. Unlike patents, trade secrets do not require public disclosure, registration, or renewal fees. They can remain protected indefinitely as long as they remain secret and the owner continues taking reasonable measures to preserve confidentiality. Those measures may include non-disclosure agreements, confidentiality provisions in employment and other contracts, access controls, password protection, employee training, limited distribution, vendor restrictions, and clear internal policies for sensitive information.
For many businesses, trade secrets are a practical form of intellectual property protection because they safeguard information that supports a competitive edge, helps preserve strategic advantages, and strengthens the company’s ability to compete.
Some of the most famous trade secrets are in the food industry, where a secret formula, secret recipe, or unique manufacturing method can become central to a company’s brand identity and long-term competitive advantage. The Coca-Cola formula is the classic example. The Coca-Cola Company states that the formula has been protected for more than 130 years, and that the formula is kept secret, placed in a vault, and safeguarded as one of the company’s most closely guarded assets. Because the exact details of the formula are not publicly disclosed, the company can preserve the mystique and market value associated with one of the world’s best-known beverages.
Kentucky Fried Chicken is another notable example. KFC’s Original Recipe uses 11 herbs and spices, and KFC has described the recipe as housed in a guarded vault, with suppliers split so no one supplier can recreate the exact mix of secret ingredients. This is a practical example of trade secret protection: the company does not merely claim the recipe is confidential; it uses physical security, limited disclosure, and divided access to help the recipe remain secret.
Other examples often discussed include a secret recipe for sauces, such as McDonald’s Big Mac sauce. While consumers may know the general flavor profile of a sauce, the precise ingredient ratios, sourcing decisions, preparation steps, shelf-stability methods, and internal quality-control specifications may still be confidential information if they are not generally known and are subject to reasonable efforts to maintain secrecy.
In the fragrance industry, perfume formulas are commonly treated as trade secrets because the commercial value often lies in the exact blend of natural and synthetic compounds, concentrations, stabilizers, and production methods. Chanel No. 5 and Dior J’adore are famous perfume formulas guarded by trade secret protection. The formula’s value depends on maintaining secrecy and preventing competitors from copying the precise scent profile. Although a competitor may attempt reverse engineering to create a “dupe,” the original brand’s exact formula, sourcing information, and manufacturing know-how may remain confidential information.
Health supplements provide another practical category of trade secret examples. In Caudill Seed & Warehouse Co. v. Jarrow Formulas, Inc., 53 F.4th 368 (6th Cir. 2022), the Sixth Circuit upheld a substantial trade secret misappropriation verdict involving proprietary research and development related to a broccoli-seed extract ingredient used in dietary supplements. The case shows that a supplement company’s commercially valuable know-how may include not only a finished formula, but also testing data, extraction methods, ingredient standardization techniques, supplier knowledge, and research showing how to achieve a desired concentration or biological effect.
Technology companies often rely on trade secrets to protect algorithms, models, source code, training data, chip designs, robotics workflows, cybersecurity methods, product roadmaps, internal analytics, and battery or manufacturing know-how. These assets can be just as important as patents because they often involve proprietary knowledge that is continuously improved and not available to competitors.
Google’s search algorithm is frequently cited as one of the world’s famous trade secrets. Google’s algorithm clearly provides a competitive advantage, as it is the most valuable asset of the search engine giant. Google's ranking systems use many factors and signals to rank hundreds of billions of web pages and generate search results quickly, but the full details of those systems are not publicly disclosed. Google's algorithm resulted in the top search engine, and facilitated Google's growth to the second highest market capitalization in history. It is clear that the secret nature of the search algorithm has resulted in immense advertising revenue and user engagement.
Apple is well known for maintaining secrecy around unreleased products, hardware designs, software features, supply-chain information, prototype devices, and internal development processes. In a consumer technology business where timing, design, and launch strategy can shape market demand, confidential information about a future iPhone, Mac, Apple Watch, chip design, or software feature provides a significant competitive edge over competitors like Samsung seeking to take some of Apple's market share. Apple’s proprietary knowledge includes exact design specifications, testing data and other sensitive data, manufacturing tolerances, supplier details, production schedules, and internal product roadmaps. Those details are commercially valuable because competitors, component suppliers, accessory makers, and market analysts may all benefit from early access to the information. Apple uses access controls, employee confidentiality obligations, restricted labs, device tracking, and need-to-know disclosure practices, to protect its confidential information and maintain trade secret status.
Tesla’s battery technology includes numerous trade secrets. Tesla has publicly discussed innovations such as 4680 battery cells, structural battery packs, tabless cell design, dry-electrode manufacturing, thermal management, and battery management software, but the exact production parameters, materials tolerances, supplier specifications, quality-control data, formation cycling protocols, and manufacturing yield improvements are not publicly disclosed. Those details are highly valuable because small differences in coating thickness, electrolyte formulation, heat control, charge-discharge calibration, pack architecture, and automated assembly workflows can affect range, charging speed, safety, durability, and cost. Tesla’s advantage is also dependent on proprietary testing data, factory automation settings, and software that manages cell performance across thousands of battery cells. Competitors may understand the general battery architecture, but not the exact details that make the system commercially efficient at scale.
In the semiconductor industry, NVIDIA publicly promotes its GPUs, AI accelerators, networking products, and software platforms, but the commercially sensitive details behind those technologies include confidential chip layouts, circuit-design choices, process optimizations, firmware, interconnect techniques, testing protocols, packaging methods, thermal-management data, and yield-improvement techniques. NVIDIA’s ability to deliver powerful GPUs for artificial intelligence workloads depends not only on the visible chip architecture, but also on proprietary know-how developed through extensive engineering, fabrication coordination, validation, and failure analysis. Internal troubleshooting data, manufacturing tolerances, supplier-specific specifications, and performance-tuning methods are highly valuable because competitors could save years of development effort if they obtained them. Those exact details provide NVIDIA with a competitive edge if they remain confidential and are protected through security measures.
In the artificial intelligence industry, Anthropic is a prominent player and the purveyor of the Claude AI services. Anthropic's commercially valuable confidential information includes the exact details of its model-training methods, curated datasets, reinforcement learning procedures, Constitutional AI techniques, safety filters, evaluation benchmarks, red-team testing results, prompt-ranking systems, and deployment infrastructure. While Anthropic publicly discusses its general approach to AI safety and alignment, the precise implementation details behind Claude’s performance, refusal behavior, reliability, and user experience are not disclosed. Those exact details provide independent economic value because competitors could use them to improve competing models, reduce development costs, or avoid costly experimentation. Anthropic’s internal safety processes, model weights, training pipelines, and evaluation data therefore function as proprietary trade secret information so long as the company takes reasonable efforts to keep them confidential through access controls, employee confidentiality obligations, and restrictions on business partners.
These examples show why trade secrets are especially important in technology. Many valuable systems are not a single invention, but a constantly changing collection of confidential data, software, and operational know-how that helps the company outperform competitors.
The federal Defend Trade Secrets Act provides federal protection and a private cause of action for trade secret misappropriation involving products or services used in interstate or foreign commerce. See 18 U.S.C. § 1836(b)(1). The DTSA is important because it allows a trade secret owner to file a civil lawsuit in federal court when someone improperly acquires, uses, or discloses protected confidential information. It also authorizes remedies such as injunctions, damages, exemplary damages for willful and malicious misappropriation, and attorneys' fees in certain cases. See 18 U.S.C. § 1836(b)(3).
The Uniform Trade Secrets Act (UTSA) provides a state-law framework for uniform trade secrets protection. Most states have adopted some version of the UTSA, although state laws can vary in wording and application. The UTSA generally defines what qualifies as a trade secret, what conduct amounts to misappropriation, and what remedies may be available, including injunctive relief, damages, and attorneys fees.
Trade secret protection also has roots in common law. Before modern statutes such as the UTSA and DTSA, courts protected trade secrets through doctrines involving confidential relationships, unfair competition, breach of confidence, fiduciary duties, and improper acquisition or use of confidential business information. Although statutes now govern most trade secret claims, common law principles may still inform how courts evaluate secrecy, improper conduct, employee duties, and related claims that arise from misuse of confidential information.
The DTSA does not generally displace other federal, state, commonwealth, or territorial remedies, so state laws still matter. See 18 U.S.C. § 1838. For many businesses, this means a trade secret case may involve both federal DTSA claims and state trade secret law claims. In litigation, Federal Rule of Civil Procedure 26(c)(1)(G) allows protective orders so trade secrets or other confidential commercial information are not revealed, or are revealed only in a specified way. These rules are especially important because filing a lawsuit should not require a company to expose the very secret information it is trying to protect.
Trade secret misappropriation is the improper acquisition, disclosure, or use of another’s trade secret without consent. Under 18 U.S.C. § 1839(5), improper acquisition and unauthorized disclosure or use can qualify. Under § 1839(6), “improper means” includes theft, bribery, misrepresentation, breach of a secrecy duty, and espionage, but not independent derivation or lawful reverse engineering.
Trade secret theft can also trigger criminal exposure under 18 U.S.C. § 1832. Remedies can include injunctions, damages, unjust enrichment, reasonable royalties, exemplary damages for willful and malicious conduct, and attorneys fees, as defined in 18 U.S.C. § 1836(b)(3).
In E.I. duPont deNemours & Co. v. Christopher, 431 F.2d 1012 (5th Cir. 1970), the court ruled that aerial photography of a plant under construction was an improper means of discovering trade secrets. The defendants had photographed DuPont’s facility from the air while the company was building a process plant, allegedly to learn confidential aspects of DuPont’s methanol production process. The court emphasized that trade secret law does not require a company to guard against every extreme or unusual method of espionage. Even though the plant was partly visible from above, using aerial surveillance to obtain secret process information could still constitute improper acquisition.
In PepsiCo, Inc. v. Redmond, 54 F.3d 1262 (7th Cir. 1995), the court recognized that strategic business plans can fall within trade secret protection where they are particularized, unknown to competitors, and competitively useful. The case also illustrates that pricing, marketing, and distribution plans may be protectable when disclosure would likely harm the company’s competitive position.
Patent protection generally requires public disclosure in exchange for exclusive rights to an invention for a limited period. Utility patents and plant patents last up to 20 years from the first non-provisional filing date, meaning patent owners receive a time-limited monopoly in exchange for disclosing the invention to the public. That bargain can be valuable when an invention is easy to inspect, copy, or reverse engineer from a finished product.
Trade secrets, by contrast, can be protected indefinitely, but only while secrecy lasts. Unlike patents, trade secrets do not require public registration, examination, or disclosure. If competitors could lawfully discover the information by reverse engineering, independent development, or observing a publicly available product, patent protection is the better option. But when competitors would struggle to discover the process because of complexity, accumulated know-how, internal testing, proprietary data, or specialized manufacturing steps, trade secret protection may provide stronger long-term strategic advantages.
However, you don't necessarily need to choose between trade secrets versus patents. More commonly, trade secrets and patents coexist around a particular technology. A technology may be patented without the disclosure of know-how related to, e.g., the most efficient way to manufacture the technology. Thus, the patentee can keep certain information related to an invention secret while still patenting the invention. The Supreme Court addressed this relationship in Kewanee Oil Co. v. Bicron Corp., 416 U.S. 470 (1974). The Court held that state trade secret law was not preempted by federal patent law, confirming that trade secrets and patents can coexist within a broader IP strategy. The Court reasoned that trade secret law protects different interests: it encourages commercial ethics, protects confidential relationships, and rewards businesses that develop valuable secret information. The Court also noted that trade secret law does not conflict with the patent system because it does not prevent others from independently inventing, using publicly available information, or lawfully reverse engineering a product.
Protecting trade secrets requires more than calling information confidential. Companies should use non-disclosure agreements, written policies and confidentiality rules for employees, employee training, access controls, secure file permissions, visitor controls, vendor restrictions, offboarding procedures, and monitoring for unusual downloads or transfers. A strong trade secret program also depends on organizational culture: employees and business partners must understand what is sensitive information, why it is highly valuable, and how to protect it. The law does not require that only one person know the secret, but it does require reasonable steps toward maintaining secrecy that can be demonstrated to a court.
Trade secrets range from technical data and proprietary systems to customer lists, formulas, algorithms, sales data, and manufacturing methods. They can give a company a durable competitive edge because competitors struggle to replicate what they cannot lawfully access. But trade secret protection is fragile: once information is publicly disclosed, casually shared, or left unprotected, the secret protection may be lost. Business owners should identify their valuable confidential information, which can be in any of the several different categories discussed above. Once identified, the trade secrets should be properly and confidentially documented and incorporated into an IP strategy, in which the trade secrets are protected through restricted access, confidentiality agreements, and internal training to control trade secret use and handling.
© 2026 Sierra IP Law, PC. The information provided herein does not constitute legal advice, but merely conveys general information that may be beneficial to the public, and should not be viewed as a substitute for legal consultation in a particular case.
A patent assignment is a transfer of all or part of the ownership of a patent. It is an important tool in the use and exploitation of patented technologies. Patent assignments allow for the monetization of patents, the transfer of technologies between businesses, and corporate management of intellectual property assets. Thus, investors, lenders, acquirers, and competitors need to understand how patent assignments work and how they can be utilized.
A patent assignment is a formal legal document that transfers rights in a patent, patent application, or other interest in patent rights from one party, the assignor, to another, the assignee. In practical terms, the assignment changes who owns the invention and related property rights. The original owner gives up the assigned ownership interest, and the assignee becomes the patent owner for the rights transferred. The assignment may cover an issued patent, an allowed application, a pending patent application, foreign patent rights, or future applications related to the same invention.
Formally, an assignment is a transfer of all or part of a party’s “right, title and interest” in a patent or patent application. Under 35 U.S.C. § 261, patents have the attributes of personal property, and patent applications and patents are assignable by an instrument in writing. That writing requirement is important: oral agreements do not transfer legal title to patent rights. The assignment document should clearly identify the parties, the invention, the application number or patent number if available, the filing date when relevant, and the specific rights being transferred.
Patent ownership determines who has the legal authority to control, commercialize, license, sell, or enforce the invention. For an issued patent, the patent owner obtains exclusive rights to exclude others from making, using, selling, offering to sell, or importing the claimed invention in the United States under 35 U.S.C. § 154(a)(1). This means ownership can directly affect whether a business can stop competitors, negotiate licensing deals, attract strategic partners, or monetize its intellectual property. Properly assigned patents also increase a company’s intangible asset value, which can be important when attracting investors, lenders, or potential buyers. Businesses often leverage patent assignments of related technologies to fast-track inventions into production because the company can consolidate patent rights in a particular area of technology under one entity, raise capital, enter manufacturing relationships, and avoid disputes over who owns the technology related to their product or service. Without clear patent ownership, a company may face enforcement problems, investor diligence issues, or competing claims from inventors, employees, contractors, or prior owners.
A patent assignment may occur at several points in the patent process: before filing, after the filing date of a patent application, during prosecution before the United States Patent and Trademark Office, or after a granted patent has a patent number. For example, inventors may assign an invention to a startup before the applicant files with the patent office, allowing the company to own and control the application from the outset. Assignments also commonly occur after filing when a business is formed, financing closes, employment obligations are confirmed, or ownership needs to be transferred to one entity. Under 35 U.S.C. § 118, a person to whom the inventor has assigned, or to whom the inventor is obliged to assign, the invention may make an application for patent. A properly executed assignment helps identify the patent owner, clarify patent rights, and support later enforcement, licensing, investment, or sale of the intellectual property.
A patent assignment agreement should clearly identify the parties, including the assignor and assignee, and should describe the invention with enough specificity to avoid later ownership disputes. The agreement should list the invention title, inventors, patent application serial number, filing date, and any issued patent number. It should state that the assignor agrees to transfer ownership and presently assigns all right, title, and interest in the patent rights to the assignee, because 35 U.S.C. § 261 requires assignments to be made by a written instrument. The provisions should also address future application filings, such as continuation, divisional, continuation-in-part, reissue, and foreign applications, if rights in foreign countries are being assigned. There are other practical matters that should be contractually addressed to avoid difficulty in formal filings with the U.S. and foreign patent offices, including obligations of the inventor(s) to cooperate in application filings, protecting confidential information, and warranties of inventorship and ownership by the transferring party(ies).
A patent assignment agreement must be in writing. Oral agreements or verbal understandings are insufficient to transfer legal title under 35 U.S.C. § 261, which provides that patents and patent applications are assignable by an instrument in writing. The assignment document should clearly identify the patent, patent application, patent number if available, assignor, assignee, and the right, title, and interest being transferred. Courts distinguish between a present assignment and a mere promise to assign in the future, so language such as “hereby assigns” is generally stronger than language stating that the inventor “will assign.” Patent assignments do not need to be notarized to be valid. However, notarization is strongly advised because an acknowledged assignment can provide prima facie evidence that the assignment, grant, or conveyance was executed. This added protection can help if one party later challenges the signature, date, authority, or enforceability of the transfer. For businesses, written and signed assignments reduce ownership disputes and support later USPTO recordation.
Patent assignments allow businesses to own inventions created by employees or independent contractors, ensuring that all invention rights are consolidated under one entity. This is critical because inventors generally own their inventions at conception unless they execute a written assignment transferring title to a company. In Stanford v. Roche, 563 U.S. 776 (2011), the Supreme Court emphasized that patent rights initially vest in the inventor, and an employer does not automatically own an employee’s invention merely because the employee worked on it during employment.
For that reason, proper assignment clauses in employment agreements are essential for securing intellectual property and preventing inventors from licensing to competitors. A company should not rely only on job duties, payroll status, or use of company resources. Instead, the employment agreement should include a present assignment of inventions, an obligation to disclose inventions, a duty to cooperate in patent filing, and a requirement to execute confirmatory assignment documents for each patent application. Similar provisions should appear in independent contractor agreements because contractors usually retain ownership unless the agreement expressly transfers patent rights.
The language matters. In Arachnid, Inc. v. Merit Industries, 939 F.2d 1574 (Fed. Cir. 1991), language stating that rights “will be assigned” was treated as a promise to assign in the future, not an immediate transfer. By contrast, in FilmTec Corp. v. Allied-Signal, 939 F.2d 1568 (Fed. Cir. 1991), present-tense assignment language was effective to automatically transfer title. A patent assignment agreement may also address compensation, confidentiality, prosecution assistance, and noncompete clauses that prevent inventors from working in the same field after assignment, although noncompete provisions require separate enforceability review under applicable state law.
A patent assignment is a permanent transfer of ownership from one entity to another. The assignor gives up its right, title, and interest in the patent, patent application, or issued patent, and the assignee becomes the new patent owner. A licensing agreement is different from an assignment because the patent owner (the licensor) retains ownership but grants permission to a licensee to use the patented technology under agreed terms. In practical terms, licensing is like renting a house, while an assignment is like selling a house.
This distinction matters because ownership affects who may enforce the patent, license others, sell the asset, and control commercialization. The Supreme Court’s Waterman v. Mackenzie, 138 U.S. 252 (1891) decision remains a leading case distinguishing assignments that convey patent title from mere licenses. The Court held that an assignment exists where the transfer conveys: (1) the whole patent; (2) an undivided part or share of the patent; or (3) the exclusive right under the patent within a specified territory. By contrast, a transfer of fewer rights is generally a license rather than an assignment.
Upon assignment, the inventor or original owner relinquishes control over how the invention is developed, priced, commercialized, or utilized. Assignment often comes with compensation such as royalties, equity, or a lump-sum payment. Patent assignments can provide immediate financial benefit to the assignor, while the assignee can generate revenue through licensing patent rights and earning royalties.
To execute a patent assignment, the parties should create a written assignment document, obtain signatures from the assignor and assignee, and record the transfer with the USPTO. Recording does not create the transfer itself, the assignment agreement does that, but recording gives public notice that the assignee claims patent ownership. This is critical because failure to record an assignment within three months of its date, or before a later purchaser or mortgagee appears, can make the transfer void against a subsequent bona fide purchaser or mortgagee for value without notice. In practical terms, late recording can cloud title, delay financing or acquisition diligence, complicate patent enforcement, and create disputes over who owns the patent rights. A company that fails to record may also face problems if an original owner later signs conflicting documents. Prompt USPTO recordation helps preserve the assignee’s priority, confirms the chain of title, reduces ownership challenges, and ensures the assignment is enforceable against third parties.
The assignment should be recorded through the USPTO Assignment Center and the Assignment Recordation Branch by submitting a recordation cover sheet and a copy of the actual assignment. Assignments of applications and patents must be accompanied by a proper cover sheet that meets the requirements of 37 C.F.R. §§ 3.28 and 3.31, when submitted. The USPTO’s Assignment Center handles patent and trademark assignment submissions. The patent office also provides how-to guides for recording assignments for patents and trademarks. Once the assignment is properly recorded, it becomes a record in the USPTO assignment records public database and can be found through an assignment search in through the USPTO’s web-based application. The ownership of the patent can be found by third parties through a patent assignment search using the patent application number, patent number, inventor name(s), and other associated data as search criteria.
A patent assignment is more than a formality. It determines who owns, controls, licenses, and can enforce valuable patent rights. For a company, the right assignment document can ensure that the company owns inventions created by employees and contractors, protect patent ownership, support investment, and preserve patent protection. Before signing, recording, or relying on an assignment, businesses should consult a patent attorney to confirm that the agreement, USPTO record, and commercial provisions match the intended transfer.
© 2026 Sierra IP Law, PC. The information provided herein does not constitute legal advice, but merely conveys general information that may be beneficial to the public, and should not be viewed as a substitute for legal consultation in a particular case.
A patentability analysis is a practical first step for an inventor, entrepreneur, or business that wants to protect a new product, software feature, device, formulation, manufacturing process, or other invention. It helps determine whether a claimed invention may satisfy the legal requirements for a U.S. patent before they spend significant resources on the patent application process. A patent search and analysis is conducted to determine whether the invention is likely new, non-obvious, and directed to proper patentable subject matter. It is essentially the due diligence that needs to be conducted before investing resources in the patent process.
A patentability analysis is a structured review of an invention under the patentability requirements of U.S. patent law. It typically begins with a comprehensive prior art search, which may include both patent databases and non-patent literature, to identify relevant prior art references and prior art documents. A basic patent search identifies potentially relevant disclosures, but a full patentability assessment goes further by conducting a detailed analysis of how the invention differs from existing technology. This includes evaluating novelty, non-obviousness, and whether the invention falls within patentable subject matter.
In practice, the analysis considers whether multiple prior art references could be combined to render the invention obvious to a person having ordinary skill in the relevant art. The resulting assessment explains potential barriers to patentability and provides a reliable assessment of the likelihood of success. This deep analysis helps businesses avoid investing in inventions that may not meet patentability standards.
A patentability analysis typically considers three areas: patent eligibility under 35 U.S.C. § 101, novelty under 35 U.S.C. § 102, and non-obviousness under 35 U.S.C. § 103. In practice, these standards operate together within the broader patentability framework to determine whether an invention qualifies for patent protection. Under § 101, the claimed invention must fall within a statutory category to be patentable. It must be a process, machine, manufacture, or composition of matter, and must avoid judicial exceptions such as abstract ideas, laws of nature, and natural phenomena, unless additional claim elements transform the patent claim into a practical application. The Supreme Court’s decisions in Alice Corp. v. CLS Bank Int’l, 573 U.S. 208 (2014), and Mayo Collaborative Services v. Prometheus Labs., 566 U.S. 66 (2012), establish a two-step test for evaluating subject matter eligibility, requiring courts and patent examiners to determine whether claims are directed to an exception and, if so, whether they include an “inventive concept.”
Novelty under § 102 requires that no single prior art reference disclose all aspects of the claimed invention, as reflected in cases such as In re Gleave, 560 F.3d 1331 (Fed. Cir. 2009). By contrast, non-obviousness under § 103 evaluates whether a skilled person would find the invention obvious in view of one or a combination of prior art references. The Supreme Court in KSR Int’l Co. v. Teleflex Inc., 550 U.S. 398 (2007), emphasized a flexible, common-sense approach to determining whether an invention is obvious, including whether combining teachings from existing technology would have been predictable.
The invention must be directed to eligible subject matter to qualify for patent protection under 35 U.S.C. § 101, which limits patentable subject matter to processes, machines, manufactures, and compositions of matter. This statutory framework is the foundation of the patent system and serves as a threshold inquiry in determining patentability. However, courts have long recognized implicit judicial exceptions excluding abstract ideas, laws of nature, and natural phenomena. As reflected in USPTO guidance and practice, a claimed invention that merely recites one of these categories without meaningful application may fail the subject matter eligibility requirement.
The Supreme Court’s decisions in Mayo Collaborative Services v. Prometheus Laboratories, 566 U.S. 66 (2012), and Alice Corp. v. CLS Bank International, 573 U.S. 208 (2014), established a now-familiar two-step framework that governs modern patent eligibility analysis. First, courts determine whether the claims are directed to a prohibited concept, such as an abstract idea, law of nature, or natural phenomenon. This step often focuses on the “focus” or “character as a whole” of the claims, which can be particularly challenging in software and business method inventions. Second, if a judicial exception is implicated, the analysis turns to whether the claim elements, individually and as an ordered combination, contain an “inventive concept” sufficient to transform the claim into a patent-eligible application. This requires more than routine, conventional, or generic implementation.
As an example, in Association for Molecular Pathology v. Myriad Genetics, 569 U.S. 576 (2013) the Court clarified that naturally occurring DNA sequences are not patentable, but synthetically created DNA (cDNA) may qualify as patentable subject matter, reinforcing the boundary between discovery and invention. Subsequent Federal Circuit decisions have refined these principles. For example, Enfish LLC v. Microsoft Corp., 822 F.3d 1327 (Fed. Cir. 2016), held that claims directed to specific improvements in computer functionality were not abstract, illustrating that technological solutions to technical problems can satisfy § 101.
Together, these authorities demonstrate that determining patentability under § 101 requires a careful, fact-specific analysis of the invention’s technical aspects and whether the invention provides a technological advancement.
A novelty search asks whether a single prior art reference discloses every element of the claimed invention, either expressly or inherently. Prior art can include patent databases, published patent applications, issued patents, online databases, technical standards, product literature, conference papers, scientific journals, and other non-patent literature. Under 35 U.S.C. § 102, a person is not entitled to a patent if the invention was patented, described in a printed publication, in public use, on sale, or otherwise available to the public before the effective filing date, subject to limited statutory exceptions such as the one-year grace period for disclosures by the inventor.
Courts have clarified that a reference anticipates a claim if it discloses all elements arranged as in the claim. For example, in Verdegaal Bros. v. Union Oil Co., 814 F.2d 628 (Fed. Cir. 1987), the Federal Circuit held that anticipation requires that each and every element be found in a single reference. Similarly, In re Gleave confirmed that even a limited disclosure may anticipate if it enables the claimed subject matter. A thorough prior art search is therefore a crucial step in any patentability assessment, as undiscovered prior art documents can present significant potential obstacles to obtaining a patent.
An invention can be new but still unpatentable if a skilled person would find the invention obvious in view of the prior art. In U.S. law, this is non-obviousness under 35 U.S.C. § 103; internationally, it is often called inventive step. Seminal obviousness cases include Graham v. John Deere Co., 383 U.S. 1 (1966), and KSR Int’l Co. v. Teleflex Inc., 550 U.S. 398 (2007). In Graham, the Supreme Court established a framework requiring analysis of (1) the scope and content of the prior art, (2) differences between the prior art and the claimed invention, and (3) the level of ordinary skill in the art, along with secondary considerations such as commercial success. In KSR, the Court emphasized a flexible, common-sense approach, rejecting rigid formulas and allowing combinations of prior art references where there is a reason to do so.
As a result, even if no single reference discloses the invention, multiple prior art documents may be combined to support obviousness rejections. A simple example is joining two known components in a predictable way, which often renders an invention obvious. USPTO guidance reflects this flexible analysis, focusing on whether the claimed invention represents more than a predictable variation of existing technology.
A strong search strategy does not rely only on obvious keywords, because relevant prior art is often described using different terminology, classifications, or technical language. Patent experts develop a structured search strategy that combines keyword searching with classification systems (such as CPC codes), assignee and inventor searches, and analysis of claim language from existing patents. They also review technical synonyms, product names, and alternative embodiments to capture variations of the same invention.
A comprehensive patentability search should extend beyond patent databases to include non-patent literature, such as scientific journals, technical standards, product manuals, and other publications that may qualify as prior art references. This broader approach is critical because non-patent literature can be just as relevant as issued patents in assessing novelty and non-obviousness.
The process typically begins with a broad search to capture a wide range of potentially relevant prior art documents, followed by iterative refinement based on initial search results. This narrowing process allows patent experts to focus on the most relevant references and conduct a more detailed analysis of how the claimed invention compares to existing technology. As part of a broader patentability assessment, this approach helps ensure a more reliable assessment of potential patentability issues.
A patentability report is usually a written report that summarizes the invention, identifies the closest search results, explains the relevant aspects of each reference, and assesses novelty, non-obviousness, subject matter eligibility, utility, and other patentability requirements. The goal is a detailed and reliable assessment, not a guarantee. A patentability opinion may also recommend whether to file, revise the invention disclosure, narrow the claims, or continue development.
Drafting a strong patent application requires understanding how the invention differs from existing technology. A patentability analysis helps a patent attorney or patent agent craft clearer claims, emphasize technical improvements over the prior art, and anticipate patent examiner concerns during patent prosecution. Known material references may also need to be disclosed to the United States Patent and Trademark Office under the duty of candor in 37 C.F.R. § 1.56, commonly through an information disclosure statement.
Even after a business performs its own analysis, the USPTO patent examiner conducts an independent examination. Under 37 C.F.R. § 1.104, the examiner studies the application and investigates available prior art relating to the claimed subject matter. That is why an early patentability assessment is best viewed as risk analysis: it helps identify potential obstacles before the Patent Office raises them. If the examiner identifies any prior art bases for rejection, an office action will issue providing the rejection and an explanation of the rejection. The patentability analysis will minimize the number of rejections. However, even with a thorough search and analysis, patent examiners often reject the application initially. Still, the patentability analysis places the application in the best posture for success.
No search can find every reference, and no analysis can guarantee allowance. New prior art may appear, claim scope may change, and the Federal Circuit may apply case law in ways that affect patentable scope. These risks notwithstanding, a patentability analysis is a critical initial step prior to filing a patent application. Even though the analysis cannot provide any guarantees of patentability, it can provide a valuable assessment of your chances of getting a patent and allow you to avoid pursuing a patent that has little prospect of success. As a practical note, the value of the assessment depends on the quality of the invention disclosure, the search, and the judgment of the trusted partner preparing it.
Patents are important assets in many industries, forming a core part of an enterprise’s intellectual property strategy. Strong patent protection can support fundraising, licensing opportunities, competitive positioning, and overall enterprise value. A reliable patentability assessment provides valuable insights before a product launch, during investor diligence, or when seeking funding, allowing businesses to make informed decisions about investing significant resources in the patenting process. It can also help control spend on intellectual property assets by identifying inventions that may not meet patentability requirements at an early stage. In addition, a thorough patentability analysis, including a prior art search and review of existing patents and non-patent literature, can provide insight into the technologies being pursued and protected by competitors. This type of detailed analysis enables companies to refine their innovation strategy, anticipate potential barriers, and better position their inventions within the marketplace.
A patentability analysis is a crucial step in determining the patentability of an invention before committing to the patent application process. It combines a prior art search with legal analysis of patent eligibility, novelty, and non-obviousness. The right patentability assessment can reveal potential barriers, guide claim strategy, reduce wasted spending, and improve the odds of building meaningful intellectual property around a commercially important invention.
If you need assistance with a patentability analysis or other intellectual property matter, please contact our offices for a consultation with one of our experienced patent attorneys.
© 2026 Sierra IP Law, PC. The information provided herein does not constitute legal advice, but merely conveys general information that may be beneficial to the public, and should not be viewed as a substitute for legal consultation in a particular case.
Sierra IP Law, PC - Patents, Trademarks & Copyrights
FRESNO
7030 N. Fruit Ave.
Suite 110
Fresno, CA 93711
(559) 436-3800 | phone
BAKERSFIELD
1925 G. Street
Bakersfield, CA 93301
(661) 200-7724 | phone
SAN LUIS OBISPO
956 Walnut Street, 2nd Floor
San Luis Obispo, CA 93401
(805) 275-0943 | phone
SACRAMENTO
180 Promenade Circle, Suite 300
Sacramento, CA 95834
(916) 209-8525 | phone
MODESTO
1300 10th St., Suite F.
Modesto, CA 95345
(209) 286-0069 | phone
SANTA BARBARA
414 Olive Street
Santa Barbara, CA 93101
(805) 275-0943 | phone
SAN MATEO
1650 Borel Place, Suite 216
San Mateo, CA, CA 94402
(650) 398-1644. | phone
STOCKTON
110 N. San Joaquin St., 2nd Floor
Stockton, CA 95202
(209) 286-0069 | phone
PORTLAND
425 NW 10th Ave., Suite 200
Portland, OR 97209
(503) 343-9983 | phone
TACOMA
1201 Pacific Avenue, Suite 600
Tacoma, WA 98402
(253) 345-1545 | phone
KENNEWICK
1030 N Center Pkwy Suite N196
Kennewick, WA 99336
(509) 255-3442 | phone
2023 Sierra IP Law, PC - Patents, Trademarks & Copyrights - All Rights Reserved - Sitemap Privacy Lawyer Fresno, CA - Trademark Lawyer Modesto CA - Patent Lawyer Bakersfield, CA - Trademark Lawyer Bakersfield, CA - Patent Lawyer San Luis Obispo, CA - Trademark Lawyer San Luis Obispo, CA - Trademark Infringement Lawyer Tacoma WA - Internet Lawyer Bakersfield, CA - Trademark Lawyer Sacramento, CA - Patent Lawyer Sacramento, CA - Trademark Infringement Lawyer Sacrament CA - Patent Lawyer Tacoma WA - Intellectual Property Lawyer Tacoma WA - Trademark lawyer Tacoma WA - Portland Patent Attorney - Santa Barbara Patent Attorney - Santa Barbara Trademark Attorney
